Document:

EX-10.2

 Exhibit 10.2 

EXECUTION VERSION 
 PURCHASE
AND SALE AGREEMENT 
 Dated as of June 29, 2018 

among 
 VARIOUS ENTITIES LISTED ON
SCHEDULE I HERETO, 
 as Originators, 

INC RESEARCH, LLC, 
 as Servicer,

 and 
 SYNEOS HEALTH
RECEIVABLES LLC, 
 as Buyer 

 CONTENTS 
  

							
	Clause	 	Subject Matter	  	Page	 
	ARTICLE I	 
	 AGREEMENT TO PURCHASE AND SELL

2
	  
  

			
	 SECTION 1.1
	 	 Agreement To Purchase and Sell
	  	 	2	 
	 SECTION 1.2
	 	 Timing of Purchases
	  	 	3	 
	 SECTION 1.3
	 	 Consideration for Purchases
	  	 	3	 
	 SECTION 1.4
	 	 Purchase and Sale Termination Date
	  	 	3	 
	 SECTION 1.5
	 	 Intention of the Parties
	  	 	3	 
	
	ARTICLE II	 
	 PURCHASE REPORT; CALCULATION OF PURCHASE PRICE

4
	  
  

			
	 SECTION 2.1
	 	 Purchase Report
	  	 	4	 
	 SECTION 2.2
	 	 Calculation of Purchase Price
	  	 	4	 
	
	ARTICLE III	 
	 CONTRIBUTIONS AND PAYMENT OF PURCHASE PRICE

5
	  
  

			
	 SECTION 3.1
	 	 Initial Contribution of Receivables and Initial Purchase Price Payment
	  	 	5	 
	 SECTION 3.2
	 	 Subsequent Purchase Price Payments
	  	 	6	 
	 SECTION 3.3
	 	 Settlement as to Specific Receivables and Dilution
	  	 	6	 
	
	ARTICLE IV	 
	 CONDITIONS OF PURCHASES; ADDITIONAL ORIGINATORS

8
	  
  

			
	 SECTION 4.1
	 	 Conditions Precedent to Initial Purchase
	  	 	8	 
	 SECTION 4.2
	 	 Certification as to Representations and Warranties
	  	 	9	 
	 SECTION 4.3
	 	 Additional Originators
	  	 	9	 
	
	ARTICLE V	 
	 REPRESENTATIONS AND WARRANTIES OF THE ORIGINATORS

10
	  
  

			
	 SECTION 5.1
	 	 Existence and Power
	  	 	10	 
	 SECTION 5.2
	 	 Power and Authority; Due Authorization
	  	 	10	 
	 SECTION 5.3
	 	 No Conflict or Violation
	  	 	10	 
	 SECTION 5.4
	 	 Governmental Approvals
	  	 	11	 
	 SECTION 5.5
	 	 Valid Sale
	  	 	11	 
	 SECTION 5.6
	 	 Binding Obligations
	  	 	11	 
	 SECTION 5.7
	 	 Accuracy of Information
	  	 	11	 
	 SECTION 5.8
	 	 Litigation and Other Proceedings
	  	 	12	 
	 SECTION 5.9
	 	 No Material Adverse Effect
	  	 	12	 
	 SECTION 5.10
	 	 Names and Location
	  	 	12	 
	 SECTION 5.11
	 	 Margin Regulations
	  	 	12	 
	 SECTION 5.12
	 	 Eligible Receivables
	  	 	12	 

  
 -i- 

 CONTENTS 
  

							
	Clause	 	Subject Matter	  	Page	 
	 SECTION 5.13
	 	 Credit and Collection Policy
	  	 	12	 
	 SECTION 5.14
	 	 Investment Company Act
	  	 	12	 
	 SECTION 5.15
	 	 Anti-Money Laundering/International Trade Law Compliance
	  	 	13	 
	 SECTION 5.16
	 	 Financial Condition
	  	 	13	 
	 SECTION 5.17
	 	 Taxes
	  	 	13	 
	 SECTION 5.18
	 	 ERISA
	  	 	13	 
	 SECTION 5.19
	 	 Bulk Sales Act
	  	 	14	 
	 SECTION 5.20
	 	 No Fraudulent Conveyance
	  	 	14	 
	 SECTION 5.21
	 	 Ordinary Course of Business
	  	 	14	 
	 SECTION 5.22
	 	 Good Title Perfection;
	  	 	14	 
	 SECTION 5.23
	 	 Additional Perfection Representations
	  	 	15	 
	 SECTION 5.24
	 	 Reliance on Separate Legal Identity
	  	 	15	 
	 SECTION 5.25
	 	 Opinions
	  	 	16	 
	 SECTION 5.26
	 	 Enforceability of Contracts
	  	 	16	 
	 SECTION 5.27
	 	 Nature of Pool Receivables
	  	 	16	 
	 SECTION 5.28
	 	 Compliance with Applicable Laws
	  	 	16	 
	 SECTION 5.29
	 	 Servicing Programs
	  	 	16	 
	 SECTION 5.30
	 	 Adverse Change in Receivables
	  	 	16	 
	 SECTION 5.31
	 	 Compliance with Transaction Documents
	  	 	16	 
	 SECTION 5.32
	 	 Reaffirmation of Representations and Warranties by each Originator
	  	 	16	 
	
	ARTICLE VI	 
	 COVENANTS OF THE ORIGINATORS

17
	  
  

			
	 SECTION 6.1
	 	 Covenants
	  	 	17	 
	 SECTION 6.2
	 	 Separateness Covenants
	  	 	23	 
	
	ARTICLE VII	 
	 ADDITIONAL RIGHTS AND OBLIGATIONS IN RESPECT OF RECEIVABLES

25
	  
  

			
	 SECTION 7.1
	 	 Rights of the Buyer
	  	 	25	 
	 SECTION 7.2
	 	 Responsibilities of the Originators
	  	 	25	 
	 SECTION 7.3
	 	 Further Action Evidencing Purchases
	  	 	25	 
	 SECTION 7.4
	 	 Application of Collections
	  	 	26	 
	 SECTION 7.5
	 	 Performance of Obligations
	  	 	26	 
	
	ARTICLE VIII	 
	 PURCHASE AND SALE TERMINATION EVENTS

26
	  
  

			
	 SECTION 8.1
	 	 Purchase and Sale Termination Events
	  	 	26	 
	 SECTION 8.2
	 	 Remedies
	  	 	27	 

  
 -ii- 

 CONTENTS 
  

							
	Clause	 	Subject Matter	  	Page	 
	ARTICLE IX	 
	 INDEMNIFICATION

27
	  
  

			
	 SECTION 9.1
	 	 Indemnities by the Originators
	  	 	27	 
	
	ARTICLE X	 
	 MISCELLANEOUS

30
	  
  

			
	 SECTION 10.1
	 	 Amendments, etc
	  	 	30	 
	 SECTION 10.2
	 	 Notices, etc
	  	 	31	 
	 SECTION 10.3
	 	 No Waiver; Cumulative Remedies
	  	 	31	 
	 SECTION 10.4
	 	 Binding Effect; Assignability
	  	 	31	 
	 SECTION 10.5
	 	 Governing Law
	  	 	31	 
	 SECTION 10.6
	 	 Costs, Expenses and Taxes
	  	 	32	 
	 SECTION 10.7
	 	 SUBMISSION TO JURISDICTION
	  	 	32	 
	 SECTION 10.8
	 	 WAIVER OF JURY TRIAL
	  	 	33	 
	 SECTION 10.9
	 	 Captions and Cross References; Incorporation by Reference
	  	 	33	 
	 SECTION 10.10
	 	 Execution in Counterparts
	  	 	33	 
	 SECTION 10.11
	 	 Acknowledgment and Agreement
	  	 	33	 
	 SECTION 10.12
	 	 No Proceeding
	  	 	33	 
	 SECTION 10.13
	 	 Mutual Negotiations
	  	 	34	 
	 SECTION 10.14
	 	 Joint and Several Liability
	  	 	34	 
	 SECTION 10.15
	 	 Severability
	  	 	34	 
	
	SCHEDULES	 
			
	 Schedule I
	 	 List and Location of Each Originator
	  			
	 Schedule II
	 	 Location of Books and Records of Originators
	  			
	 Schedule III
	 	 Trade Names
	  			
	 Schedule IV
	 	 Notice Addresses
	  			
	 Schedule V
	 	 Actions/Suits
	  			
	
	EXHIBITS	 
			
	 Exhibit A
	 	 Form of Purchase Report
	  			
	 Exhibit B
	 	 Form of Intercompany Loan Agreement
	  			
	 Exhibit C
	 	 Form of Joinder Agreement
	  			

  
 -iii- 

 This PURCHASE AND SALE AGREEMENT (as amended, restated, supplemented or otherwise modified from
time to time, this “Agreement”), dated as of June 29, 2018 is entered into among the VARIOUS ENTITIES LISTED ON SCHEDULE I HERETO (the “Originators” and each, an “Originator”), INC
RESEARCH, LLC, a Delaware limited liability company, as initial Servicer (as defined below) (“INC Research”), and SYNEOS HEALTH RECEIVABLES LLC, a Delaware limited liability company (the “Buyer”). 

DEFINITIONS 
 Unless otherwise
indicated herein, capitalized terms used and not otherwise defined in this Agreement are defined in Article I of the Receivables Financing Agreement, dated as of the date hereof (as the same may be amended, restated, supplemented or otherwise
modified from time to time, the “Receivables Financing Agreement”), among the Buyer, as borrower, INC Research, as initial Servicer (in such capacity, the “Servicer”), the Persons from time to time party thereto as
Lenders, PNC Bank, National Association, as Administrative Agent and PNC Capital Markets, LLC, as Structuring Agent. All references hereto to months are to calendar months unless otherwise expressly indicated. All accounting terms not specifically
defined herein shall be construed in accordance with GAAP. All terms used in Article 9 of the UCC in the State of New York, and not specifically defined herein, are used herein as defined in such Article 9. Unless the context otherwise requires,
“or” means “and/or,” and “including” (and with correlative meaning “include” and “includes”) means including without limiting the generality of any description preceding such term. 

BACKGROUND 

1.    The Buyer is a special purpose limited liability company, all of the issued and outstanding membership interests of
which are owned by INC Research (“Contributing Originator”). 
 2.    The Originators generate
Receivables in the ordinary course of their businesses. 
 3.    The Originators wish to sell and/or, in the case of the
Contributing Originator, contribute Receivables and the Related Rights to the Buyer, and the Buyer is willing to purchase and/or accept such Receivables and the Related Rights from the Originators, on the terms and subject to the conditions set
forth herein. 
 4.    The Originators and the Buyer intend each such transaction to be a true sale and/or, in the case
of Contributing Originator, an absolute contribution and conveyance of Receivables and the Related Rights by each Originator to the Buyer, providing the Buyer with the full benefits of ownership of the Receivables, and the Originators and the Buyer
do not intend the transactions hereunder to be characterized as a loan from the Buyer to any Originator. 
 5.    The
Buyer intends to pledge the Receivables and the Related Rights to the Administrative Agent pursuant to the Receivables Financing Agreement. 

  

					
		 		 	Purchase and Sale Agreement

 NOW, THEREFORE, in consideration of the premises and the mutual agreements herein contained, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows: 
 ARTICLE I

 AGREEMENT TO PURCHASE AND SELL 

SECTION 1.1 Agreement To Purchase and Sell. On the terms and subject to the conditions set forth in this Agreement, each Originator,
severally and for itself, agrees to sell to the Buyer, and the Buyer agrees to purchase from such Originator, from time to time on or after the Closing Date, but before the Purchase and Sale Termination Date (as defined in
Section 1.4), all of such Originator’s right, title and interest in and to: 

(a)    each Receivable (other than Contributed Receivables as defined in Section 3.1(a)) of such
Originator that existed and was owing to such Originator at the closing of such Originator’s business on the Cut-Off Date (as defined below); 

(b)    each Receivable (other than Contributed Receivables) generated by such Originator from and including the Cut-Off Date to but excluding the Purchase and Sale Termination Date; 
 (c)    all of
such Originator’s interest in any goods (including Returned Goods), and documentation of title evidencing the shipment or storage of any goods (including Returned Goods), the sale of which gave rise to such Receivable; 

(d)    all instruments and chattel paper that may evidence such Receivable; 

(e)    all other security interests or liens and property subject thereto from time to time purporting to secure payment
of such Receivable, whether pursuant to the Contract related to such Receivable or otherwise, together with all UCC financing statements or similar filings relating thereto; 

(f)    solely to the extent applicable to such Receivable, all of such Originator’s rights, interests and claims
under the related Contract and all guaranties, indemnities, insurance and other agreements (including the related Contract) or arrangements of whatever character from time to time supporting or securing payment of such Receivable or otherwise
relating to such Receivable, whether pursuant to the Contract related to such Receivable or otherwise; 
 (g)    all
books and records of such Originator to the extent related to any of the foregoing, and all rights, remedies, powers, privileges, title and interest (but not obligations) in and to each Lock-Box and all
Collection Accounts, into which any Collections or other proceeds with respect to such Receivables may be deposited, and any related investment property acquired with any such Collections or other proceeds (as such term is defined in the applicable
UCC); and 
 (h)    all Collections and other proceeds (as defined in the UCC) of any of the foregoing that are or were
received by such Originator on or after the Cut-Off Date, including, without limitation, all funds which either are received by such Originator, the Buyer or the Servicer from or on behalf of the Obligors in
payment of any amounts owed (including, without limitation, invoice price, finance charges, interest and all other charges) in respect of any of the above Receivables or are applied to such amounts owed by the Obligors (including, without
limitation, any insurance payments that such Originator, the Buyer or the Servicer applies in the ordinary course of its business to amounts owed in respect of any of the above Receivables, and 

  
 2 

 
net proceeds of sale or other disposition of Returned Goods or other collateral of the Obligors in respect of any of the above Receivables or any other parties directly or indirectly liable for
payment of such Receivables). 
 All purchases and contributions hereunder shall be made without recourse, but shall be made pursuant to, and in reliance
upon, the representations, warranties and covenants of the Originators set forth in this Agreement. No obligation or liability to any Obligor on any Receivable is intended to be assumed by the Buyer hereunder, and any such assumption is expressly
disclaimed. The property, proceeds and rights described in clauses (c) through (h) above, including with respect to any Contributed Receivable, are herein referred to as the “Related Rights”, and the Buyer’s
foregoing commitment to purchase Receivables and Related Rights is herein called the “Purchase Facility.” 
 As used
herein, “Cut-Off Date” means (a) with respect to each Originator party hereto on the date hereof, May 31, 2018, and (b) with respect to any Originator that first becomes a party
hereto after the date hereof, the calendar day prior to the date on which such Originator becomes a party hereto or such other date as the Buyer and such Originator agree to in writing. 

SECTION 1.2 Timing of Purchases. 

(a)    Closing Date Purchases. Effective on the Closing Date, each Originator hereby sells to the Buyer, and the
Buyer hereby purchases, such Originator’s entire right, title and interest in, to and under (i) each Receivable (other than Contributed Receivables) that existed and was owing to such Originator at the
Cut-Off Date, (ii) each Receivable (other than Contributed Receivables) generated by such Originator from and including the Cut-Off Date, to and including the
Closing Date, and (iii) all Related Rights with respect thereto. 
 (b)    Subsequent Purchases. After the
Closing Date, until the Purchase and Sale Termination Date, each Receivable and the Related Rights generated by each Originator shall be, and shall be deemed to have been, sold or contributed, as applicable, by such Originator to the Buyer
immediately (and without further action) upon the creation of such Receivable. 
 SECTION 1.3 Consideration for Purchases. On the
terms and subject to the conditions set forth in this Agreement, the Buyer agrees to make Purchase Price payments to the Originators and to reflect all capital contributions in accordance with Article III. 

SECTION 1.4 Purchase and Sale Termination Date. The “Purchase and Sale Termination Date” shall be the earlier to occur
of (a) the date the Purchase Facility is terminated pursuant to Section 8.2(a) and (b) the Final Payout Date. 

SECTION 1.5 Intention of the Parties. It is the express intent of each Originator and the Buyer that each conveyance by such Originator
to the Buyer pursuant to this Agreement of the Receivables, including without limitation, all Receivables, if any, constituting general intangibles as defined in the UCC, and all Related Rights be construed as a valid and perfected sale (or
contribution) and absolute assignment (without recourse except as provided herein) of such Receivables and Related Rights by such Originator to the Buyer (rather than the grant of a security interest to secure a debt or other obligation of such
Originator) and that the right, title and interest in and to such Receivables and Related Rights conveyed to the Buyer be prior to the 

  
 3 

 
rights of and enforceable against all other Persons at any time, including, without limitation, lien creditors, secured lenders, purchasers and any Person claiming through such Originator.
Notwithstanding the foregoing, (i) this Agreement also shall be deemed to be, and hereby is, a security agreement within the meaning of the UCC and (ii) each Originator shall be deemed to have granted to the Buyer as of the date of this
Agreement, and such Originator hereby grants to the Buyer a security interest in, to and under all of such Originator’s right, title and interest in and to: (A) the Receivables and the Related Rights now existing and hereafter created by
such Originator transferred or purported to be transferred hereunder, (B) all monies due or to become due and all amounts received with respect thereto and (C) all books and records of such Originator to the extent related to any of the
foregoing. 
 ARTICLE II 

PURCHASE REPORT; CALCULATION OF PURCHASE PRICE 

SECTION 2.1 Purchase Report. On the Closing Date and on each date when an Information Package is due to be delivered under the
Receivables Financing Agreement (each such date, a “Monthly Purchase Report Date”), the Servicer shall deliver to the Buyer and each Originator a report in substantially the form of Exhibit A (each such report being herein
called a “Purchase Report”) setting forth, among other things: 
 (a)    Receivables purchased by the
Buyer from each Originator, or contributed to the capital of the Buyer by Contributing Originator, on the Closing Date (in the case of the Purchase Report to be delivered on the Closing Date); 

(b)    Receivables purchased by the Buyer from each Originator, or contributed to the capital of the Buyer by Contributing
Originator, during the calendar month immediately preceding such Monthly Purchase Report Date (in the case of each subsequent Purchase Report); and 

(c)    the calculations of reductions of the Purchase Price for any Receivables as provided in
Section 3.3(a) and (b). 
 SECTION 2.2 Calculation of Purchase Price. The “Purchase
Price” to be paid to each Originator on any Payment Date in accordance with the terms of Article III for the Receivables and the Related Rights that are purchased hereunder from such Originator shall be determined in accordance with
the following formula: 
  

					
	PP	  	=	  	OB x FMVD
			
	where:	  		  	
			
	PP	  	=	  	Purchase Price for each Receivable as calculated on the relevant Payment Date.
			
	OB	  	=	  	The Outstanding Balance of such Receivable on the relevant Payment Date.
			
	FMVD	  	=	  	Fair Market Value Discount, as measured on such Payment Date, which is equal to the quotient (expressed as percentage) of (a) one, divided by (b) the sum of (i) one, plus (ii) the product
of (A) the Prime Rate on such Payment Date, times (B) a fraction, the numerator of which is the Days’ Sales Outstanding (calculated as of the last day of the calendar month immediately preceding such Payment Date) and the
denominator of which is 365 or 366, as applicable.

  
 4 

 “Payment Date” means (i) the Closing Date and (ii) each Business Day
thereafter that the Originators are open for business. 
 “Prime Rate” means a per annum rate equal to
the “U.S. Prime Rate” as published in the “Money Rates” section of The Wall Street Journal or if such information ceases to be published in The Wall Street Journal, such other comparable publication as determined by the
Administrative Agent in its reasonable discretion. 
 ARTICLE III 

CONTRIBUTIONS AND PAYMENT OF PURCHASE PRICE 

SECTION 3.1 Initial Contribution of Receivables and Initial Purchase Price Payment. 

(a)    On the Closing Date, Contributing Originator shall, and hereby does, contribute to the capital of the Buyer
Receivables and Related Rights consisting of each Receivable of Contributing Originator that exists and is owing to Contributing Originator on the Closing Date beginning with the oldest of such Receivables and continuing chronologically thereafter
such that the equity (taking into account any cash contributions made on or prior to the Closing Date) held by Contributing Originator in the Buyer, after giving effect to such contribution of Receivables (the value of which shall be determined
based on the Purchase Price definition), shall be at least equal to the Required Capital Amount. Each Receivable contributed by Contributing Originator to the capital of the Buyer pursuant to this Section 3.1(a) and
Section 3.2 below is herein referred to as a “Contributed Receivable”. 

(b)    On the terms and subject to the conditions set forth in this Agreement, the Buyer agrees to pay to each Originator
the Purchase Price for the purchase to be made from such Originator on the Closing Date (i) to the extent the Buyer has cash available therefor, partially in cash (in an amount to be agreed between the Buyer and such Originator and set forth in
the initial Purchase Report) and, solely in the case of Contributing Originator if elected by Contributing Originator in its sole discretion, by accepting a contribution to the Buyer’s capital and (ii) the remainder by accepting an
Intercompany Loan from such Originator that was made under an intercompany loan agreement in the form of Exhibit B (each such intercompany loan agreement, as it may be amended, supplemented or otherwise modified from time to time, each being
herein called an “Intercompany Loan Agreement”) with an initial principal amount equal to the remaining Purchase Price payable to such Originator not paid in cash or, in the case of Contributing Originator, contributed to the
Buyer’s capital. 
 As used herein, “Intercompany Loan” has the meaning set forth in the related Intercompany Loan
Agreement. 

  
 5 

 SECTION 3.2 Subsequent Purchase Price Payments. On each Payment Date subsequent to the
Closing Date, on the terms and subject to the conditions set forth in this Agreement, the Buyer shall pay the Purchase Price to each Originator for the Receivables and the Related Rights generated by such Originator on such Payment Date: 

(a)    First, in cash to each Originator to the extent the Buyer has cash available therefor (and such
payment is not prohibited under the Receivables Financing Agreement); 
 (b)    Second, solely in the case
of Contributing Originator, if elected by Contributing Originator in its sole discretion, to the extent any portion of the Purchase Price remains unpaid, by accepting a contribution of such Receivable and the Related Rights to its capital in an
amount equal to such remaining unpaid portion of such Purchase Price; and 
 (c)    Third, to the extent
any portion of the Purchase Price remains unpaid, an Intercompany Loan shall automatically be made by such Originator to the Buyer with an initial principal amount equal to the lesser of (x) such remaining unpaid portion of such Purchase Price
and (y) the maximum amount that could be made without rendering the Buyer’s Net Worth less than the Required Capital Amount;  

provided, however, that if more than one Originator is selling Receivables to the Buyer on the date of such purchase, the Buyer shall make cash
payments among the Originators in such a way as to minimize to the greatest extent practicable the aggregate outstanding principal amount of all Intercompany Loans; provided, further, however, that the foregoing shall not be
construed to require Contributing Originator to make any capital contribution to the Buyer. 
 “Net Worth” has the meaning
set forth under “Borrower’s Net Worth” in the Receivables Financing Agreement. 
 All amounts paid by the Buyer to any
Originator shall be allocated first to the payment of any Purchase Price then due and unpaid, second to the payment of accrued and unpaid interest on the Intercompany Loans made by such Originator and third to the repayment of
the outstanding principal amount on the Intercompany Loans made by such Originator to the extent of such outstanding principal amount thereof as of the date of such payment before such amounts may be allocated for any other purpose. The Servicer
shall make all appropriate record keeping entries with respect to each of the Intercompany Loans to reflect the foregoing payments and payments and reductions made pursuant to Section 3.3, and absent manifest error, such
entries shall constitute prima facie evidence of the accuracy of the information so entered. 
 If, on any Business Day, the Buyer is unable
to pay the Purchase Price for Receivables and Related Rights pursuant to this Section 3.2, then the Originators shall on such Business Day provide written notice thereof to the Administrative Agent. 

SECTION 3.3 Settlement as to Specific Receivables and Dilution. 

(a)    If, (i) on the day of purchase of any Receivable from an Originator hereunder, any of the representations or
warranties set forth in Sections 5.5, 5.12, 5.20, 5.22, 5.23, 5.26 or 5.27 are not true with respect to such Receivable or (ii) as a result of any action or inaction (other than solely as a
result of the failure to collect such Receivable due to a discharge 

  
 6 

 
in bankruptcy or similar insolvency proceeding or other credit related reasons with respect to the relevant Obligor) of such Originator, on any subsequent day, any of such representations or
warranties set forth in Sections 5.5, 5.12, 5.20, 5.22, 5.23, 5.26 or 5.27 is no longer true with respect to such Receivable, then the Purchase Price for such Receivable shall be reduced by an amount
equal to the Outstanding Balance of such Receivable and shall be accounted to such Originator as provided in clause (c) below; provided, that if the Buyer thereafter receives payment on account of the Outstanding Balance of such
Receivable, the Buyer promptly shall deliver such funds to such Originator. 
 (b)    If, on any day, the Outstanding
Balance of any Receivable purchased or contributed hereunder is either (i) reduced or canceled as a result of (A) any defective, rejected or returned goods or services, any cash or other discount, or any failure by an Originator to deliver
any goods or perform any services or otherwise perform under the underlying Contract or invoice, (B) any change in or cancellation of any of the terms of such Contract or invoice or any other adjustment by an Originator, the Servicer or the
Buyer which reduces the amount payable by the Obligor on the related Receivable, (C) any rebates, warranties, allowances or charge-backs or (D) any setoff or credit in respect of any claim by the Obligor thereof (whether such claim arises
out of the same or a related transaction or an unrelated transaction), or (ii) subject to any specific dispute, offset, counterclaim or defense whatsoever (except the discharge in bankruptcy of the Obligor thereof), then the Purchase Price with
respect to such Receivable shall be reduced by the amount of such net reduction or dispute and shall be accounted to such Originator as provided in clause (c) below. 

(c)    Any reduction in the Purchase Price of any Receivable pursuant to clause (a) or (b) above shall
be applied as a credit for the account of the Buyer against the Purchase Price of Receivables subsequently purchased by the Buyer from such Originator hereunder; provided, however if there have been no purchases of Receivables from
such Originator (or insufficiently large purchases of Receivables prior to the Settlement Date immediately following any such reduction in the Purchase Price of any Receivable) to create a Purchase Price sufficient to so apply such credit against,
the amount of such credit: 
 (i)    to the extent of any outstanding principal balance under the
Intercompany Loans made by such Originator, shall be deemed to be a payment under, and shall be deducted from the outstanding principal amount of, the Intercompany Loans made by such Originator; and 

(ii)    after making any deduction pursuant to clause (i) above, shall be paid in cash to the
Buyer by such Originator on such Settlement Date subject to the following proviso; 
 provided, further, that at any time (x) when
an Event of Default or an Unmatured Event of Default, exists under the Receivables Financing Agreement or (y) on or after the Purchase and Sale Termination Date, the amount of any such credit shall be paid by such Originator to the Buyer in
cash by deposit of immediately available funds into a Collection Account for application by the Servicer to the same extent as if Collections of the applicable Receivable in such amount had actually been received on such date. 

  
 7 

 ARTICLE IV 

CONDITIONS OF PURCHASES; ADDITIONAL ORIGINATORS 

SECTION 4.1 Conditions Precedent to Initial Purchase. The initial purchase hereunder is subject to the condition precedent that the
Buyer and the Administrative Agent (as the Buyer’s assignee) shall have received, on or before the Closing Date, the following, each (unless otherwise indicated) dated the Closing Date, and each in form and substance satisfactory to the Buyer
and the Administrative Agent (as the Buyer’s assignee): 
 (a)    a copy of the resolutions or unanimous written
consent of the board of directors or other governing body of each Originator, approving this Agreement and the other Transaction Documents to be executed and delivered by it and the transactions contemplated hereby and thereby, certified by the
Secretary or Assistant Secretary of such Originator; 
 (b)    good standing certificates for each Originator issued as
of a recent date acceptable to the Buyer and the Administrative Agent (as the Buyer’s assignee) by the Secretary of State (or similar official) of the jurisdiction of such Originator’s organization or formation and each other jurisdiction
where such Originator is required to be qualified to transact business, except where the failure to be so qualified would not reasonably be expected to have a Material Adverse Effect; 

(c)    a certificate of the Secretary or Assistant Secretary of each Originator, certifying the names and true signatures
of the officers authorized on such Person’s behalf to sign this Agreement and the other Transaction Documents to be executed and delivered by it (on which certificate the Servicer, the Buyer, the Administrative Agent (as the Buyer’s
assignee) and each Lender may conclusively rely until such time as the Servicer, the Buyer and the Administrative Agent (as the Buyer’s assignee) shall receive from such Person a revised certificate meeting the requirements of this
clause (c)); 
 (d)    the certificate or articles of incorporation or other organizational
document of each Originator (including all amendments and modifications thereto) duly certified by the Secretary of State (or similar official) of the jurisdiction of such Originator’s organization as of a recent date, together with a copy of
the by-laws or other governing documents of such Originator (including all amendments and modifications thereto), as applicable, each duly certified by the Secretary or an Assistant Secretary of such
Originator; 
 (e)    proper financing statements (Form UCC-1) that have been
duly authorized and name each Originator as the debtor/seller and the Buyer as the buyer/assignor (and the Administrative Agent, for the benefit of the Lenders, as secured party/assignee) of the Receivables generated by such Originator as may be
necessary or, in the Buyer’s or the Administrative Agent’s reasonable opinion, desirable under the UCC of all appropriate jurisdictions to perfect the Buyer’s ownership or security interest in such Receivables and the Related Rights
in which an ownership or security interest has been assigned to it hereunder; 
 (f)    a written search report from a
Person satisfactory to the Buyer and the Administrative Agent (as the Buyer’s assignee) listing all effective financing statements that name the Originators as debtors or sellers and that are filed in all jurisdictions in which filings

  
 8 

 
may be made against such Person pursuant to the applicable UCC, together with copies of such financing statements (none of which, except for those described in the foregoing clause (e)
(and/or released or terminated, as the case may be, prior to the date hereof), shall cover any Receivable or any Related Rights which are to be sold to the Buyer hereunder), and tax and judgment lien search reports (including, without limitation,
liens of the PBGC) from a Person satisfactory to the Buyer and the Administrative Agent (as the Buyer’s assignee) showing no evidence of such liens filed against any Originator; 

(g)    favorable opinions of counsel to the Originators, in form and substance satisfactory to the Buyer and the
Administrative Agent; 
 (h)    a copy of an Intercompany Loan Agreement entered into by each Originator and the Buyer,
duly executed by such Originator and the Buyer; and 
 (i)    evidence (i) of the execution and delivery by each of
the parties thereto of each of the other Transaction Documents to be executed and delivered by it in connection herewith and (ii) that each of the conditions precedent to the execution, delivery and effectiveness of such other Transaction
Documents has been satisfied to the Buyer’s and the Administrative Agent’s (as the Buyer’s assignee) satisfaction. 
 SECTION
4.2 Certification as to Representations and Warranties. Each Originator, by accepting the Purchase Price related to each purchase or contribution of Receivables generated by such Originator, shall be deemed to have certified that the
representations and warranties of such Originator contained in Article V, as from time to time amended in accordance with the terms hereof, are true and correct in all material respects (unless such representation or warranty contains a
materiality qualification and, in such case, such representation and warranty shall be true and correct as made) on and as of such day, with the same effect as though made on and as of such day (except for representations and warranties which apply
to an earlier date, in which case such representations and warranties shall be true and correct in all material respects (unless such representation or warranty contains a materiality qualification and, in such case, such representation and warranty
shall be true and correct as made) as of such earlier date). 
 SECTION 4.3 Additional Originators. Additional Persons may be added
as Originators hereunder, with the prior written consent of the Buyer, the Administrative Agent and each Lender (which consents may be granted or withheld in their sole discretion); provided that the following conditions are satisfied or
waived in writing by the Administrative Agent and each Lender on or before the date of such addition: 
 (a)    the
Servicer shall have given the Buyer, the Administrative Agent and each Lender at least thirty (30) days’ prior written notice of such proposed addition and the identity of the proposed additional Originator and shall have provided such
other information with respect to such proposed additional Originator as the Buyer, the Administrative Agent or any Lender may reasonably request; 

(b)    such proposed additional Originator shall have executed and delivered to the Buyer and the Administrative Agent an
agreement substantially in the form attached hereto as Exhibit C (a “Joinder Agreement”); 

  
 9 

 (c)    such proposed additional Originator shall have delivered to the Buyer
and the Administrative Agent (as the Buyer’s assignee) each of the documents with respect to such Originator described in Section 4.1, in each case in form and substance satisfactory to the Buyer and the Administrative
Agent (as the Buyer’s assignee); 
 (d)    no Purchase and Sale Termination Event or Unmatured Purchase and Sale
Termination Event shall have occurred and be continuing; and 
 (e)    no Event of Default or Unmatured Event of Default
shall have occurred and be continuing. 
 ARTICLE V 

REPRESENTATIONS AND WARRANTIES OF THE ORIGINATORS 

In order to induce the Buyer to enter into this Agreement and to make purchases hereunder, each Originator (and solely with respect to
Section 5.21, the Buyer) hereby represents and warrants with respect to itself that each representation and warranty concerning it or the Receivables sold by it hereunder that is contained in the Receivables Financing
Agreement is true and correct, and hereby makes the representations and warranties set forth in this Article V: 
 SECTION 5.1
Existence and Power. Such Originator (i) is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization or formation, (ii) has full power and authority under its organizational
documents and under the laws of the jurisdiction of its organization or formation to own its properties and to conduct its business as such properties are currently owned and such business is presently conducted and (iii) is duly qualified to
do business, is in good standing as a foreign entity and has obtained all necessary licenses and approvals in all jurisdictions in which the conduct of its business requires such qualification, licenses or approvals, except where the failure to do
so could not reasonably be expected to have a Material Adverse Effect. 
 SECTION 5.2 Power and Authority; Due Authorization. Such
Originator (i) has all necessary power and authority to (A) execute and deliver this Agreement and the other Transaction Documents to which it is a party, (B) perform its obligations under this Agreement and the other Transaction
Documents to which it is a party and (C) grant a security interest in the Receivables and the Related Rights to the Buyer on the terms and subject to the conditions herein provided and (ii) has duly authorized by all necessary action such
grant and the execution, delivery and performance of, and the consummation of the transactions provided for in, this Agreement and the other Transaction Documents to which it is a party. 

SECTION 5.3 No Conflict or Violation. The execution, delivery and performance of, and the consummation of the transactions contemplated
by, this Agreement and the other Transaction Documents to which such Originator is a party, and the fulfillment of the terms hereof and thereof, will not (i) conflict with, result in any breach of any of the terms or provisions of, or
constitute (with or without notice or lapse of time or both) a default under its organizational documents or any indenture, sale agreement, credit agreement (including the Credit Agreement), loan agreement, security agreement, mortgage, deed of
trust or other agreement or instrument to which such Originator is a party or by which it or any of its 

  
 10 

 
properties is bound, (ii) result in the creation or imposition of any Adverse Claim upon any of the Collateral pursuant to the terms of any such indenture, credit agreement (including the
Credit Agreement), loan agreement, security agreement, mortgage, deed of trust or other agreement or instrument, other than this Agreement and the other Transaction Documents or (iii) conflict with or violate any Applicable Law, except to the
extent that any such conflict, breach, default, Adverse Claim or violation could not reasonably be expected to have a Material Adverse Effect. 

SECTION 5.4 Governmental Approvals. Except where the failure to obtain or make such authorization, consent, order, approval or action
could not reasonably be expected to have a Material Adverse Effect, all authorizations, consents, orders and approvals of, or other actions by, any Governmental Authority that are required to be obtained by such Originator in connection with the
grant of a security interest in the Receivables and the Related Rights to the Buyer hereunder or the due execution, delivery and performance by such Originator of this Agreement or any other Transaction Document to which it is a party and the
consummation by such Originator of the transactions contemplated by this Agreement and the other Transaction Documents to which it is a party have been obtained or made and are in full force and effect. 

SECTION 5.5 Valid Sale. Each sale of Receivables and the Related Rights made by such Originator pursuant to this Agreement shall
constitute a valid sale (or, with respect to the Contributing Originator, contribution), transfer and assignment of Receivables and Related Rights to the Buyer, enforceable against creditors of, and purchasers from, such Originator, except
(i) as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and (ii) as such enforceability may be limited
by general principles of equity, regardless of whether such enforceability is considered in a proceeding in equity or at law. 
 SECTION 5.6
Binding Obligations. This Agreement and each of the other Transaction Documents to which it is a party constitute legal, valid and binding obligations of such Originator, enforceable against such Originator in accordance with their respective
terms, except (i) as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and (ii) as such enforceability
may be limited by general principles of equity, regardless of whether such enforceability is considered in a proceeding in equity or at law. 

SECTION 5.7 Accuracy of Information. All certificates, reports, statements, documents and other information furnished to the Buyer, the
Administrative Agent or any other Credit Party by or on behalf of such Originator pursuant to any provision of this Agreement or any other Transaction Document, or in connection with or pursuant to any amendment or modification of, or waiver under,
this Agreement or any other Transaction Document, is, at the time the same are so furnished, complete and correct in all material respects on the date the same are furnished to the Buyer, the Administrative Agent or such other Credit Party, and does
not contain any material misstatement of fact or omit to state a material fact necessary to make the statements contained therein not misleading; provided, that with respect to projected financial information, if any, such representation is
made only that such information was prepared in good faith based upon assumptions believed to be reasonable at the time. 

  
 11 

 SECTION 5.8 Litigation and Other Proceedings. Except as set forth on Schedule V,
(i) there is no action, suit, proceeding or investigation pending or, to the best knowledge of such Originator, threatened, against such Originator before any Governmental Authority and (ii) such Originator is not subject to any order,
judgment, decree, injunction, stipulation or consent order of or with any Governmental Authority that, in the case of either of the foregoing clauses (i) and (ii), (A) asserts the invalidity of this Agreement or any other
Transaction Document, (B) seeks to prevent the grant of a security interest in any Receivable or Related Right by such Originator to the Buyer, the ownership or acquisition by the Buyer of any Receivables or Related Right or the consummation of
any of the transactions contemplated by this Agreement or any other Transaction Document, (C) seeks any determination or ruling that could materially and adversely affect the performance by such Originator of its obligations under, or the
validity or enforceability of, this Agreement or any other Transaction Document or (D) individually or in the aggregate for all such actions, suits, proceedings and investigations could reasonably be expected to have a Material Adverse Effect.

 SECTION 5.9 No Material Adverse Effect. Since December 31, 2017, there has been no Material Adverse Effect on such
Originator. 
 SECTION 5.10 Names and Location. Except as described in Schedule III, such Originator has not used any
corporate names, trade names or assumed names since the date occurring five calendar years prior to the Closing Date other than its name set forth on the signature pages hereto. Such Originator is “located” (as such term is defined in the
applicable UCC) in the jurisdiction specified in Schedule I and since the date occurring five calendar years prior to the Closing Date, has not been “located” (as such term is defined in the applicable UCC) in any other jurisdiction
(except as specified in Schedule I). The office(s) where such Originator keeps its records concerning the Receivables is at the address(es) set forth on Schedule II. 

SECTION 5.11 Margin Regulations. Such Originator is not engaged, principally or as one of its important activities, in the business of
extending credit for the purpose of purchasing or carrying margin stock (within the meanings of Regulations T, U and X of the Board of Governors of the Federal Reserve System), and no Purchase Price payments or proceeds under this Agreement will be
used to purchase or carry any margin stock or to extend credit to others for the purpose of purchasing or carrying any margin stock. 

SECTION 5.12 Eligible Receivables. Each Receivable sold, transferred, contributed or assigned hereunder is an Eligible Receivable on
the date of sale, transfer, contribution or assignment, unless otherwise specified in the first Interim Report or Information Package that includes such Receivable. 

SECTION 5.13 Credit and Collection Policy. Such Originator has complied in all material respects with the Credit and Collection Policy
with regard to each Receivable sold by it hereunder and the related Contracts. 
 SECTION 5.14 Investment Company Act. Such
Originator is not an “investment company,” or a company “controlled” by an “investment company,” within the meaning of the Investment Company Act. 

  
 12 

 SECTION 5.15 Anti-Money Laundering/International Trade Law Compliance. Such Originator is
not a Sanctioned Person. Such Originator, either in its own right or through any third party, (i) does not have any of its assets in a Sanctioned Country or in the possession, custody or control of a Sanctioned Person in violation of any
Anti-Terrorism Law; (ii) neither does business in or with, nor derives any of its income from investments in or transactions with, any Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law; or (iii) does not engage
in any dealings or transactions prohibited by any Anti-Terrorism Law. 
 SECTION 5.16 Financial Condition. 

(a)    The audited consolidated balance sheets of Parent and its consolidated Subsidiaries as of December 31, 2017 and
the related statements of income and shareholders’ equity of Parent and its consolidated Subsidiaries for the fiscal year then ended, copies of which have been furnished to the Administrative Agent and the Lenders, present fairly in all
material respects the consolidated financial position of Parent and its consolidated Subsidiaries for the period ended on such date, all in accordance with GAAP. 

(b)    On the date hereof, and on the date of each purchase hereunder (both before and after giving effect to such
purchase), such Originator is, and will be on such date, Solvent and no Insolvency Proceeding with respect to such Originator is, or will be on such date, pending or threatened. 

SECTION 5.17 Taxes. Such Originator has (i) timely filed all tax returns (federal, state, foreign and local) required to be filed
by it and (ii) paid, or caused to be paid, all taxes, assessments and other governmental charges, if any, other than taxes, assessments and other governmental charges being contested in good faith by appropriate proceedings and as to which
adequate reserves have been provided in accordance with GAAP, except in each case to the extent that the failure to file or pay could not reasonably be expected to have a Material Adverse Effect. 

SECTION 5.18 ERISA. 

(a)    Each of the Parent and its ERISA Affiliates is in compliance with the applicable provisions of ERISA and the
provisions of the Code relating to Pension Plans and Multiemployer Plans and the regulations and published interpretations thereunder and any similar applicable non-U.S. law, except for such noncompliance that
would not reasonably be expected to have a Material Adverse Effect. No Reportable Event has occurred during the past five years other than a Reportable Event that would not reasonably be expected to have a Material Adverse Effect. The excess of the
present value of all benefit liabilities under each Pension Plan (based on the assumptions used to determine required minimum contributions under Section 412 of the Code with respect to such Pension Plan), over the value of the assets of such
Pension Plan, determined as of the most recent annual valuation date applicable thereto for which a valuation has been completed, would not reasonably be expected to have a Material Adverse Effect, and the excess of the present value of all benefit
liabilities of all underfunded Pension Plans (based on the assumptions used to determine required minimum contributions under Section 412 of the Code with respect to each such Pension Plan), over the value of the assets of all such under funded
Pension Plans, determined as of the most recent annual valuation 

  
 13 

 
dates applicable thereto for which valuations have been completed, would not reasonably be expected to have a Material Adverse Effect. None of the Parent or its ERISA Affiliates has received any
written notification that any Multiemployer Plan is insolvent or has been terminated within the meaning of Title IV of ERISA, or has knowledge that any Multiemployer Plan is reasonably expected to be insolvent or to be terminated, where such
insolvency or termination has had or would reasonably be expected to have, through increases in the contributions required to be made to such Multiemployer Plan or otherwise, a Material Adverse Effect. 

(b)    Each of the Parent and the ERISA Affiliates is in compliance (i) with all applicable provisions of law and all
applicable regulations and published interpretations thereunder with respect to any employee pension benefit plan governed by the laws of a jurisdiction other than the United States and (ii) with the terms of any such plan, except, in each
case, for such noncompliance that would not reasonably be expected to have a Material Adverse Effect. 
 SECTION 5.19 Bulk Sales Act.
No transaction contemplated by this Agreement requires compliance by it with any bulk sales act or similar law. 
 SECTION 5.20 No
Fraudulent Conveyance. No sale or contribution hereunder constitutes a fraudulent transfer or conveyance under any United States federal or applicable state bankruptcy or insolvency laws or is otherwise void or voidable under such or similar
laws or principles or for any other reason. 
 SECTION 5.21 Ordinary Course of Business. Each of the Originators and the Buyer
represents and warrants as to itself that each remittance of Collections by or on behalf of such Originator to the Buyer under this Agreement will have been (i) in payment of a debt incurred by such Originator in the ordinary course of business
or financial affairs of such Originator and the Buyer and (ii) made in the ordinary course of business or financial affairs of such Originator and the Buyer. 

SECTION 5.22 Good Title Perfection;. 

(a)    Immediately preceding its sale or contribution of each Receivable hereunder, such Originator was the owner of such
Receivable sold or contributed or purported to be sold or contributed, as the case may be, free and clear of any Adverse Claims (other than Permitted Adverse Claims), and each such sale or contribution hereunder constitutes a valid sale or
contribution, transfer and assignment of all of such Originator’s right, title and interest in, to and under the Receivables sold or contributed by it, free and clear of any Adverse Claims (other than Permitted Adverse Claims). 

(b)    On or before the date hereof and before the generation by such Originator of any new Receivable to be sold,
contributed or otherwise conveyed hereunder, all financing statements and other documents, if any, required to be recorded or filed in order to perfect and protect the Buyer’s ownership interest in Receivables to be sold or otherwise conveyed
hereunder against all creditors of and purchasers from such Originator will have been duly filed in each filing office necessary for such purpose, and all filing fees and taxes, if any, payable in connection with such filings shall have been paid in
full. 

  
 14 

 (c)    Upon the creation of each new Receivable sold, contributed or
otherwise conveyed or purported to be conveyed hereunder and on the Closing Date for then existing Receivables, the Buyer shall have a valid and perfected first priority ownership or security interest in each Receivable sold to it hereunder, free
and clear of any Adverse Claim (other than Permitted Adverse Claims). 
 SECTION 5.23 Additional Perfection Representations.

 (a)    This Agreement creates a valid and continuing ownership or security interest (as defined in the
applicable UCC) in the Originator’s right, title and interest in, to and under the Receivables and Related Rights which (A) security interest has been perfected and is enforceable against creditors of and purchasers from such Originator
and (B) will be free of all Adverse Claims (other than Permitted Adverse Claims). 
 (b)    The
Receivables constitute “accounts” or “general intangibles” within the meaning of Section 9-102 of the UCC. 

(c)    Prior to their sale or contribution to Buyer pursuant to this Agreement, such Originator owned and
had good and marketable title to the Receivables and Related Rights free and clear of any Adverse Claim (other than a Permitted Adverse Claim) of any Person. 

(d)    All appropriate financing statements, financing statement amendments and continuation statements
have been filed in the proper filing office in the appropriate jurisdictions under Applicable Law in order to perfect (and continue the perfection of) the sale and contribution of the Receivables and Related Rights from each Originator to the Buyer
pursuant to this Agreement. 
 (e)    Other than the ownership or security interest granted to the Buyer
pursuant to this Agreement, such Originator has not pledged, assigned, sold, granted a security interest in, or otherwise conveyed any of the Receivables or Related Rights except as permitted by this Agreement and the other Transaction Documents.
Such Originator has not authorized the filing of and is not aware of any financing statements filed against such Originator that include a description of collateral covering the Receivables and Related Rights other than any financing statement
(i) in favor of the Administrative Agent or (ii) that has been terminated or amended to reflect the release of any security interest in the Receivables and Related Rights. Such Originator is not aware of any judgment lien, ERISA lien or
tax lien filings against such Originator. 
 (f)    Notwithstanding any other provision of this Agreement
or any other Transaction Document, the representations contained in this Section 5.23 shall be continuing and remain in full force and effect until the Final Payout Date. 

SECTION 5.24 Reliance on Separate Legal Identity. Such Originator acknowledges that each of the Lenders and the Administrative Agent
are entering into the Transaction Documents to which they are parties in reliance upon the Buyer’s identity as a legal entity separate from such Originator. 

  
 15 

 SECTION 5.25 Opinions. The facts regarding such Originator, the Receivables sold or
contributed by it hereunder, the Related Security and the related matters set forth or assumed in each of the opinions of counsel delivered in connection with this Agreement and the Transaction Documents are true and correct in all material
respects. 
 SECTION 5.26 Enforceability of Contracts. Each Contract related to any Receivable sold or contributed by such Originator
hereunder is effective to create, and has created, a legal, valid and binding obligation of the related Obligor to pay the outstanding balance of such Receivable, enforceable against the Obligor in accordance with its terms. 

SECTION 5.27 Nature of Pool Receivables. All Pool Receivables: (i) were originated by such Originator in the ordinary course of
its business, (ii) were sold to Buyer for fair consideration and reasonably equivalent value and (iii) represent all, or a portion of the purchase price of merchandise, insurance or services within the meaning of Section 3(c)(5)(A) of
the Investment Company Act. The purchase of Pool Receivables with the proceeds of Credit Extensions made under the Receivables Financing Agreement would constitute a “current transaction” for purposes of Section 3(a)(3) of the
Securities Act. 
 SECTION 5.28 Compliance with Applicable Laws. Each Originator is in compliance with the requirements of all laws,
rules and regulations applicable to its property or business operations, except in such instance where any failure to comply therewith, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect. 

SECTION 5.29 Servicing Programs. No material license or approval is required for Servicer or Buyer’s use of any software or other
computer program used by such Originator in the servicing of the Receivables, other than those that have been obtained and are in full force and effect. 

SECTION 5.30 Adverse Change in Receivables. Since December 31, 2017, there has been no material adverse change in either the
collectability or the payment history of the Receivables originated by such Originator taken as a whole. 
 SECTION 5.31 Compliance with
Transaction Documents. Each Originator has complied in all material respects with all of the terms, covenants and agreements contained in the other Transaction Documents to which it is a party. 

SECTION 5.32 Reaffirmation of Representations and Warranties by each Originator. On each day that a new Receivable is created, and when
sold or contributed to the Buyer hereunder, such Originator shall be deemed to have certified that all representations and warranties set forth in this Article V are true and correct in all material respects on and as of such day as though
made on and as of such day, except for representations and warranties which apply as to an earlier date (in which case such representations and warranties shall be true and correct in all material respects as of such date). Notwithstanding any other
provision of this Agreement or any other Transaction Document, the representations contained in this Article shall be continuing and remain in full force and effect until the Final Payout Date. 

  
 16 

 ARTICLE VI 

COVENANTS OF THE ORIGINATORS 

SECTION 6.1 Covenants. At all times from the Closing Date until the Final Payout Date, each Originator will, unless the
Administrative Agent and the Buyer shall otherwise consent in writing, perform the following covenants: 

(a)    Financial Reporting. Each Originator will maintain a system of accounting established and administered in
accordance with GAAP, and each Originator shall furnish to the Buyer, the Administrative Agent and each Lender such information as the Buyer, the Administrative Agent or any Lender may from time to time reasonably request relating to such system.

 (b)    Notices. Such Originator will notify the Buyer, Administrative Agent and each Lender in
writing of any of the following events promptly upon (but in no event later than five (5) Business Days after) a Financial Officer learning of the occurrence thereof (unless a different notice period is set forth for the event in the relevant
subsections below), with such notice describing the same, and if applicable, the steps being taken by the Person(s) affected with respect thereto: 

(i)    Notice of Purchase and Sale Termination Events, Unmatured Purchase and Sale Termination Events,
Events of Default or Unmatured Events of Default. A statement of a Financial Officer of such Originator setting forth details of any Purchase and Sale Termination Event (as defined in Section 8.1), Unmatured Purchase
and Sale Termination Event (as defined in Section 8.1), Event of Default or Unmatured Event of Default that has occurred and is continuing and the action which such Originator proposes to take with respect thereto. 

(ii)    Representations and Warranties. The failure of any representation or warranty made or deemed
to be made by such Originator under this Agreement or any other Transaction Document to be true and correct in any material respect when made. 

(iii)    Litigation. The institution of any litigation, arbitration proceeding or governmental
proceeding with respect to such Originator, the Buyer, the Servicer, the Performance Guarantor or any other Originator, which with respect to any Person other than the Buyer, could reasonably be expected to have a Material Adverse Effect. 

(iv)    Adverse Claim. (A) Any Person shall obtain an Adverse Claim (other than a
Permitted Adverse Claim) upon Receivables or Related Rights or any portion thereof, (B) any Person other than an Originator, the Buyer, the Servicer or the Administrative Agent shall obtain any rights or direct any action with respect to any
Collection Account (or related Lock-Box) or (C) any Obligor shall receive any change in payment instructions with respect to Pool Receivable(s) from a Person other than an Originator, the Servicer or the
Administrative Agent. 

  
 17 

 (v)    Name Changes. At least thirty (30) days
before any change in such Originator’s name, jurisdiction of organization or any other change requiring the amendment of UCC financing statements. 

(vi)    Change in Accountants or Accounting Policy. Any change in (A) the external accountants
of such Originator, the Servicer, any other Originator, the Performance Guarantor or the Parent or (B) any material accounting policy of such Originator that is relevant to the transactions contemplated by this Agreement or any other
Transaction Document (it being understood that any change to the manner in which such Originator accounts for the Pool Receivables shall be deemed “material” for such purpose). 

(c)    Conduct of Business; Preservation of Existence. Each Originator will carry on and conduct its business in
substantially the same manner and in substantially the same fields of enterprise as it is presently conducted or fields complimentary or ancillary thereto and will do all things necessary to preserve and keep in full force and effect its existence
and, except where the failure to do so would not reasonably be expected to have a Material Adverse Effect, its franchises, authority to do business in each jurisdiction in which its business is conducted, licenses, patents, trademarks, copyrights
and other proprietary rights; provided however, that nothing in this paragraph (c) shall prevent any transaction permitted by paragraph (n) below or not otherwise prohibited by this Agreement or any other
Transaction Document. 
 (d)    Compliance with Laws. Each Originator will comply with all Applicable Laws to
which it may be subject if the failure to comply could reasonably be expected to have a Material Adverse Effect. 

(e)    Furnishing of Information and Inspection of Receivables. Each Originator will furnish or cause to be
furnished to the Buyer, the Administrative Agent and each Lender from time to time such information with respect to the Pool Receivables as the Buyer, the Administrative Agent or any Lender may reasonably request. Each Originator will, at such
Originator’s expense, during regular business hours with reasonable prior written notice, (i) permit the Buyer, the Administrative Agent and each Lender or their respective agents or representatives to (A) examine and make copies of
and abstracts from all books and records relating to the Pool Receivables or other Collateral, (B) visit the offices and properties of such Originator for the purpose of examining such books and records, and (C) discuss matters relating to
the Pool Receivables, the other Collateral or such Originator’s performance hereunder or under the other Transaction Documents to which it is a party with any of the officers, directors, employees or independent public accountants of such
Originator (provided that representatives of such Originator are present during such discussions) having knowledge of such matters and (ii) without limiting the provisions of clause (i) above, during regular business hours, at such
Originator’s expense, upon reasonable prior written notice from the Buyer or the Administrative Agent, permit certified public accountants or other auditors acceptable to the Buyer or the Administrative Agent, as applicable, to conduct a review
of its books and records with respect to such Pool Receivables and other Collateral; provided, that such Originator shall be required to reimburse the Buyer and the Administrative Agent for only one (1) combined review of the Originators
pursuant to clause (ii) above in any twelve-month period, unless an Event of Default has occurred and is continuing. 

  
 18 

 (f)    Payments on Receivables, Collection Accounts. Each Originator
will, at all times, instruct all Obligors to deliver payments on the Pool Receivables to a Collection Account or a Lock-Box. Each Originator (or the Servicer on its behalf) will at all times, maintain such
books and records necessary to identify Collections received from time to time on Pool Receivables and to segregate such Collections from property of the Originators. If any payments on the Pool Receivables or other Collections are received by an
Originator, the Buyer or the Servicer, it shall hold (or cause such Originator, the Buyer or the Servicer to hold) such payments in trust for the benefit of the Buyer (and the Administrative Agent and the Lenders as the Buyer’s assignees) and
promptly (but in any event within one (1) Business Day after becoming aware of such receipt) remit such funds into a Collection Account. The Originators will use commercially reasonable efforts to ensure that each Collection Account Bank
complies with the terms of each applicable Account Control Agreement. The Originators shall instruct (i) all obligors on Excluded Receivables and (ii) all payors of amounts owing to the Originators or their Affiliates (which do not
constitute Pool Receivables or other Collateral), in each case, to remit payments with respect thereto to any bank account or other location that does not constitute a Collection Account or a Lock-Box. The
Originators shall use commercially reasonable efforts to ensure that no funds other than Collections on Pool Receivables and other Collateral are deposited into any Collection Account. If such funds are nevertheless deposited into any Collection
Account, the Originators will cause the Servicer to, within two (2) Business Days identify and transfer such funds to the appropriate Person entitled to such funds. The Originators will not, and will not permit any other Person to, commingle
Collections with any other funds. The Originators shall only add (or permit the Servicer to add) a Collection Account (or a related Lock-Box) or a Collection Account Bank to those listed in the Receivables
Financing Agreement, if the Administrative Agent has received notice of such addition and an executed and acknowledged copy of an Account Control Agreement (or an amendment thereto) in form and substance acceptable to the Administrative Agent from
the applicable Collection Account Bank. The Originators shall only terminate (or permit the Servicer to terminate) a Collection Account Bank or close a Collection Account (or a related Lock-Box) with the prior
written consent of the Administrative Agent. The Originators shall ensure that no disbursements are made from any Collection Account, other than such disbursements that are made at the direction and for the account of the Buyer. 

(g)    Sales, Liens, etc. Except as otherwise provided herein, no Originator will sell, assign (by operation of law
or otherwise) or otherwise dispose of, or create or suffer to exist any Adverse Claim (other than a Permitted Adverse Claim) upon (including, without limitation, the filing of any financing statement) or with respect to, any Pool Receivable or other
Related Rights, or assign any right to receive income in respect thereof. 
 (h)    Extension or Amendment of Pool
Receivables. Except as otherwise permitted by the Receivables Financing Agreement, no Originator will, or will permit the Servicer to, alter the delinquency status or adjust the Outstanding Balance or otherwise modify the terms of any
Pool Receivable in any material respect, or amend, modify or waive, in any material respect, any term or condition of any related Contract. Each Originator shall at its expense, timely and fully perform and comply in all material respects with all
provisions, covenants and other promises required to be observed by it under the Contracts related to the Pool Receivables, and timely and fully comply in all material respects with the Credit and Collection Policy with regard to each Pool
Receivable and the related Contract. 

  
 19 

 (i)    Fundamental Changes. Each Originator shall not make any change
in such Originator’s name, location or make any other change in such Originator’s identity or corporate structure that could impair or otherwise render any UCC financing statement filed in connection with this Agreement or the Receivables
Financing Agreement “seriously misleading” as such term (or similar term) is used in the applicable UCC, in each case, unless the Buyer, the Administrative Agent and each Lender have each (A) received 30 days’ prior notice
thereof, (B) consented in writing thereto (such consent not to be unreasonably withheld), (C) received executed copies of all documents, certificates and opinions (including, without limitation, opinions relating to bankruptcy and UCC matters)
as the Buyer or the Administrative Agent shall reasonably request and (D) been reasonably satisfied that all other action to perfect and protect the interests of the Buyer and the Administrative Agent, on behalf of the Lenders, in and to the
Receivables to be sold by it hereunder and other Related Rights, as reasonably requested by the Buyer or the Administrative Agent shall have been taken by, and at the expense of, such Originator (including the filing of any UCC financing statements,
the receipt of certificates and other requested documents from public officials and all such other actions required pursuant to Section 7.3). 

(j)    Change in Credit and Collection Policy. No Originator will make, or direct the Servicer to make, any change
in the Credit and Collection Policy that would reasonably be expected to either (x) have a material adverse effect on the collectability of the Pool Receivables or (y) have a Borrower Material Adverse Effect or a Material Adverse Effect,
in each case, without the prior written consent of the Administrative Agent and the Majority Lenders. Promptly following any material change in the Credit and Collection Policy, the Originator will deliver a copy of the updated Credit and Collection
Policy to the Buyer, Administrative Agent and each Lender. 
 (k)    Books and Records. Each Originator will
maintain and implement (or cause the Servicer to maintain and implement) administrative and operating procedures (including an ability to recreate records evidencing Pool Receivables and related Contracts in the event of the destruction of the
originals thereof), and keep and maintain (or cause the Servicer to keep and maintain) all documents, books, records, computer tapes and disks and other information reasonably necessary or advisable for the collection of all Pool Receivables
(including records adequate to permit the daily identification of each Pool Receivable and all Collections of and adjustments to each existing Pool Receivable). 

(l)    Ownership Interest, Etc. Each Originator shall (and shall cause the Servicer to), at its expense, take all
action necessary to establish and maintain a valid and enforceable ownership or security interest in the Pool Receivables, the Related Rights and Collections with respect thereto, and a first priority perfected security interest in the Collateral,
in each case free and clear of any Adverse Claim (other than a Permitted Adverse Claim), in favor of the Buyer (and the Administrative Agent (on behalf of the Lenders), as the Buyer’s assignee), including taking such action to perfect, protect
or more fully evidence the interest of the Buyer (and the Administrative Agent (on behalf of the Lenders), as the Buyer’s assignee) as the Buyer, the Administrative Agent or any Lender may reasonably request. In order to evidence the security
interests of the Administrative Agent under this Agreement, such Originator shall, from time to time take such action, or execute and deliver such instruments as may be necessary (including, without limitation, such actions as are reasonably
requested by the Administrative 

  
 20 

 
Agent) to maintain and perfect, as a first-priority interest, the Administrative Agent’s security interest in the Receivables, Related Security and Collections. Such Originator shall, from
time to time and within the time limits established by law, prepare and present to the Administrative Agent for the Administrative Agent’s authorization and approval, all financing statements, amendments, continuations or initial financing
statements in lieu of a continuation statement, or other filings necessary to continue, maintain and perfect the Administrative Agent’s security interest as a first-priority interest. The Administrative Agent’s approval of such filings
shall authorize such Originator to file such financing statements under the UCC without the signature of such Originator, any Originator or the Administrative Agent where allowed by Applicable Law. Notwithstanding anything else in the Transaction
Documents to the contrary, such Originator shall not have any authority to file a termination, partial termination, release, partial release, or any amendment that deletes the name of a debtor or excludes collateral of any such financing statements
filed in connection with the Transaction Documents, without the prior written consent of the Administrative Agent. 

(m)    Further Assurances. Each Originator hereby authorizes and hereby agrees from time to time, at its own
expense, promptly to execute (if necessary) and deliver all further instruments and documents, and to take all further actions, that may be necessary or desirable, or that the Buyer or the Administrative Agent may reasonably request, to perfect,
protect or more fully evidence the purchases and contributions made hereunder or under the Receivables Financing Agreement and/or security interest granted pursuant to the Receivables Financing Agreement or any other Transaction Document, or to
enable the Buyer or the Administrative Agent (on behalf of the Lenders) to exercise and enforce their respective rights and remedies hereunder, under the Receivables Financing Agreement or under any other Transaction Document. Without limiting the
foregoing, such Originator hereby authorizes, and will, upon the request of the Buyer or the Administrative Agent, at such Originator’s own expense, execute (if necessary) and file such financing statements or continuation statements, or
amendments thereto, and such other instruments and documents, that may be necessary, or that the Buyer or Administrative Agent may reasonably request, to perfect, protect or evidence any of the foregoing. 

(n)    Mergers, Acquisitions, Sales, etc. Such Originator shall not (i) be a party to any merger,
consolidation or other restructuring, except a merger, consolidation or other restructuring where the Buyer, the Administrative Agent and each Lender have each (A) received 30 days’ prior notice thereof, (B) consented in writing
thereto (such consent not to be unreasonably withheld, conditioned or delayed), (C) received executed copies of all documents, certificates and opinions (including, without limitation, opinions relating to bankruptcy and UCC matters) as the Buyer or
the Administrative Agent shall reasonably request and (D) been satisfied that all other action to perfect and protect the interests of the Buyer and the Administrative Agent, on behalf of the Lenders, in and to the Receivables to be sold by it
hereunder and other Related Rights, as reasonably requested by the Buyer or the Administrative Agent shall have been taken by, and at the expense of, such Originator (including the filing of any UCC financing statements, the receipt of certificates
and other requested documents from public officials and all such other actions required pursuant to Section 7.3) or (ii) directly or indirectly sell, transfer, assign, convey or lease (A) whether in one or a
series of transactions, all or substantially all of its assets or (B) any Receivables or any interest therein (other than pursuant to this Agreement). 

  
 21 

 (o)    Frequency of Billing. Prepare and deliver (or cause to be
prepared and delivered) invoices with respect to all Receivables in accordance with the Credit and Collection Policies, but in any event no less frequently than as required under the Contract related to such Receivable. 

(p)    Receivables Not to Be Evidenced by Promissory Notes or Chattel Paper. Such Originator shall not take any
action to cause or permit any Receivable created, acquired or originated by it to become evidenced by any “instrument” or “chattel paper” (as defined in the applicable UCC) without the prior written consent of the Buyer and the
Administrative Agent. 
 (q)    Anti-Money Laundering/International Trade Law Compliance. Such Originator will
not become a Sanctioned Person. Such Originator, either in its own right or through any third party, will not (a) have any of its assets in a Sanctioned Country or in the possession, custody or control of a Sanctioned Person in violation of any
Anti-Terrorism Law; (b) do business in or with, or derive any of its income from investments in or transactions with, any Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law; (c) engage in any dealings or
transactions prohibited by any Anti-Terrorism Law or (d) use the proceeds from the sale of the Receivables to fund any operations in, finance any investments or activities in, or, make any payments to, a Sanctioned Country or Sanctioned Person
in violation of any Anti-Terrorism Law. Such Originator shall comply with all Anti-Terrorism Laws. Such Originator shall promptly notify the Administrative Agent and each Lender in writing upon the occurrence of a Reportable Compliance Event. 

(r)    Legend. Each Originator (or the Servicer on its behalf) shall have placed on the most recent, and have taken
all steps reasonably necessary to ensure that there shall be placed on each subsequent, data processing report that it generates which are of the type that a proposed purchaser or lender would use to evaluate the Receivables, the following legend
(or the substantive equivalent thereof): “THE RECEIVABLES DESCRIBED HEREIN HAVE BEEN SOLD PURSUANT TO A PURCHASE AND SALE AGREEMENT, DATED AS OF JUNE 29, 2018, AS AMENDED, BETWEEN EACH OF THE ENTITIES LISTED ON SCHEDULE I THERETO, AS
ORIGINATORS, INC RESEARCH, LLC, AS SERVICER AND SYNEOS HEALTH RECEIVABLES LLC, AS BUYER; AND THE RECEIVABLES DESCRIBED HEREIN HAVE BEEN PLEDGED TO PNC BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT, PURSUANT TO A RECEIVABLES FINANCING
AGREEMENT, DATED AS OF JUNE 29, 2018, AS AMENDED, AMONG SYNEOS HEALTH RECEIVABLES LLC, AS BORROWER, INC RESEARCH, LLC, AS SERVICER, THE VARIOUS LENDERS FROM TIME TO TIME PARTY THERETO AND PNC BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE
AGENT”. 
 (s)    Buyer’s Tax Status. Neither INC Research nor any Originator shall take or cause any
action to be taken that could result in the Buyer (i) being treated other than as a “disregarded entity” within the meaning of U.S. Treasury Regulation § 301.7701-3 for U.S. federal income
tax purposes or (ii) becoming an association taxable as a corporation or a publicly traded partnership taxable as a corporation for U.S. federal income tax purposes. 

  
 22 

 (t)    Insurance. Such Originator will maintain in effect, at such
Originator’s expense, such casualty and liability insurance as such Originator deems appropriate in its good faith business judgment. 

(u)    Intercompany Loans, Etc. Such Originator will not sell, assign (by operation of law or otherwise) or
otherwise dispose of, or grant any option with respect to, or create or suffer to exist any Adverse Claim upon (including, without limitation, the filing of any financing statement) or with respect to, any Intercompany Loan Agreement or any
Intercompany Loan. 
 (v)    Other Additional Information. Such Originator will provide to the Administrative
Agent and the Lenders such information and documentation as may reasonably be requested by the Administrative Agent or any Lender from time to time for purposes of compliance by the Administrative Agent or such Lender with applicable laws (including
without limitation the PATRIOT Act and other “know your customer” and anti-money laundering rules and regulations), and any policy or procedure implemented by the Administrative Agent or such Lender to comply therewith. 

SECTION 6.2 Separateness Covenants. Each Originator hereby acknowledges that this Agreement and the other Transaction Documents are
being entered into in reliance upon the Buyer’s identity as a legal entity separate from such Originator and its Affiliates. Therefore, from and after the date hereof, each Originator shall take all reasonable steps necessary to make it
apparent to third Persons that the Buyer is an entity with assets and liabilities distinct from those of such Originator and any other Person, and is not a division of such Originator, its Affiliates or any other Person. Without limiting the
generality of the foregoing and in addition to and consistent with the other covenants set forth herein, such Originator shall take such actions as shall be required in order that: 

(a)    such Originator shall not be involved in the
day-to-day management of the Buyer; 

(b)    such Originator shall maintain separate records and books of account from the Buyer and otherwise will observe
corporate formalities and have a separate area from the Buyer for its business (which may be located at the same address as the Buyer, and, to the extent that it and the Buyer have offices in the same location, there shall be a fair and appropriate
allocation of overhead costs between them, and each shall bear its fair share of such expenses); 
 (c)    the financial
statements and books and records of such Originator shall be prepared after the date of creation of the Buyer to reflect and shall reflect the separate existence of the Buyer; provided, that the Buyer’s assets and liabilities may be
included in a consolidated financial statement issued by an Affiliate of the Buyer; provided, however, that any such consolidated financial statement or the notes thereto shall make clear that the Buyer’s assets are not available
to satisfy the obligations of such Affiliate; 
 (d)    except as permitted by the Receivables Financing Agreement,
(i) such Originator shall maintain its assets (including, without limitation, deposit accounts) separately from the assets (including, without limitation, deposit accounts) of the Buyer and (ii) such Originator’s assets, and records
relating thereto, have not been, are not, and shall not be, commingled with those of the Buyer; 

  
 23 

 (e)    such Originator shall not act as an agent for the Buyer (except in the
capacity of Servicer or a Sub-Servicer); 
 (f)    such Originator shall not
conduct any of the business of the Buyer in its own name (except in the capacity of Servicer or a Sub-Servicer); 

(g)    such Originator shall not pay any liabilities of the Buyer out of its own funds or assets; 

(h)    such Originator shall maintain an arm’s-length relationship with the
Buyer; 
 (i)    such Originator shall not assume or guarantee or become obligated for the debts of the Buyer or hold
out its credit as being available to satisfy the obligations of the Buyer; 
 (j)    such Originator shall not acquire
obligations of the Buyer (other than the Intercompany Loan Agreements and the Intercompany Loans); 
 (k)    such
Originator shall allocate fairly and reasonably overhead or other expenses that are properly shared with the Buyer, including, without limitation, shared office space; 

(l)    such Originator shall identify and hold itself out as a separate and distinct entity from the Buyer; 

(m)    such Originator shall correct any known misunderstanding respecting its separate identity from the Buyer; 

(n)    such Originator shall not enter into, or be a party to, any transaction with the Buyer, except in the ordinary
course of its business and on terms which are intrinsically fair and not less favorable to it than would be obtained in a comparable arm’s-length transaction with an unrelated third party; 

(o)    such Originator shall not pay the salaries of the Buyer’s employees, if any; and 

(p)    to the extent not already covered in paragraphs (a) through (o) above, such Originator shall
comply and/or act in accordance with all of the other separateness covenants set forth in Section 8.03 of the Receivables Financing Agreement. 

  
 24 

 ARTICLE VII 

ADDITIONAL RIGHTS AND OBLIGATIONS 

IN RESPECT OF RECEIVABLES 

SECTION 7.1 Rights of the Buyer. Each Originator hereby authorizes the Buyer, the Servicer or their respective designees or assignees
under this Agreement or the Receivables Financing Agreement (including, without limitation, the Administrative Agent) to take any and all steps in such Originator’s name necessary or desirable, in their respective determination, to collect all
amounts due under any and all Receivables sold, contributed or otherwise conveyed or purported to be conveyed by it hereunder, including, without limitation, endorsing the name of such Originator on checks and other instruments representing
Collections and enforcing such Receivables and the provisions of the related Contracts that concern payment and/or enforcement of rights to payment; provided, however, the Administrative Agent shall not take any of the foregoing
actions unless a Purchase and Sale Termination Event or an Event of Default has occurred and is continuing. 
 SECTION 7.2
Responsibilities of the Originators. Anything herein to the contrary notwithstanding: 
 (a)    Each Originator
shall perform its obligations hereunder, and the exercise by the Buyer or its designee of its rights hereunder shall not relieve such Originator from such obligations. 

(b)    None of the Buyer, the Servicer, the Lenders or the Administrative Agent shall have any obligation or liability to
any Obligor or any other third Person with respect to any Receivables, Contracts related thereto or any other related agreements, nor shall the Buyer, the Servicer, the Lenders or the Administrative Agent be obligated to perform any of the
obligations of such Originator thereunder. 
 (c)    Each Originator hereby grants to the Administrative Agent an
irrevocable power-of-attorney, with full power of substitution, coupled with an interest, during the occurrence and continuation of an Event of Default to take in the
name of such Originator all steps necessary or advisable to endorse, negotiate or otherwise realize on any writing or other right of any kind held or transmitted by such Originator or transmitted or received by the Buyer (whether or not from such
Originator) in connection with any Receivable sold, contributed or otherwise conveyed or purported to be conveyed by it hereunder or Related Right. 

SECTION 7.3 Further Action Evidencing Purchases. On or prior to the Closing Date, each Originator shall mark its master data processing
records evidencing Pool Receivables and Contracts with a legend, acceptable to the Buyer and the Administrative Agent, evidencing that the Pool Receivables have been transferred in accordance with this Agreement and none of the Originators or
Servicer shall change or remove such notation without the consent of the Buyer and the Administrative Agent. Each Originator agrees that from time to time, at its expense, it will promptly execute and deliver all further instruments and documents,
and take all further action that the Buyer, the Servicer, the Administrative Agent or any Lender may reasonably request in order to perfect, protect or more fully evidence the Receivables and Related Rights purchased by or contributed to the Buyer
hereunder, or to enable the Buyer to exercise or enforce any of its rights hereunder or under any other Transaction Document. Without limiting the generality of the foregoing, upon the request of the Buyer, the Administrative Agent or any Lender,
such Originator will execute (if applicable), authorize and file such financing or continuation statements, or amendments thereto or assignments thereof, and such other instruments or notices, as may be necessary or appropriate. 

  
 25 

 Each Originator hereby authorizes the Buyer or its designee or assignee (including, without limitation, the
Administrative Agent) to file one or more financing or continuation statements, and amendments thereto and assignments thereof, relative to all or any of the Receivables and Related Rights sold or otherwise conveyed or purported to be conveyed by it
hereunder and now existing or hereafter generated by such Originator. If any Originator fails to perform any of its agreements or obligations under this Agreement, the Buyer or its designee or assignee (including, without limitation, the
Administrative Agent) may (but shall not be required to) itself perform, or cause the performance of, such agreement or obligation, and the expenses of the Buyer or its designee or assignee (including, without limitation, the Administrative Agent)
incurred in connection therewith shall be payable by such Originator. 
 SECTION 7.4 Application of Collections. Any payment by an
Obligor in respect of any indebtedness owed by it to any Originator shall, except as otherwise specified by such Obligor or required by Applicable Law and unless otherwise instructed by the Servicer (with the prior written consent of the
Administrative Agent) or the Administrative Agent, be applied as a Collection of any Receivable or Receivables of such Obligor to the extent of any amounts then due and payable thereunder (such application to be made starting with the oldest
outstanding Receivable or Receivables) before being applied to any other indebtedness of such Obligor. 
 SECTION 7.5 Performance of
Obligations. Each Originator shall (i) perform all of its obligations under the Contracts related to the Receivables generated by such Originator to the same extent as if interests in such Receivables had not been transferred hereunder, and
the exercise by the Buyer or the Administrative Agent of its rights hereunder shall not relieve any Originator from any such obligations and (ii) pay when due any taxes, including, without limitation, any sales taxes payable in connection with
the Receivables generated by such Originator and their creation and satisfaction. 
 ARTICLE VIII 

PURCHASE AND SALE TERMINATION EVENTS 

SECTION 8.1 Purchase and Sale Termination Events. Each of the following events or occurrences described in this
Section 8.1 shall constitute a “Purchase and Sale Termination Event” (each event which with notice or the passage of time or both would become a Purchase and Sale Termination Event being referred to herein
as an “Unmatured Purchase and Sale Termination Event”): 
 (a)    the Termination Date shall have
occurred; 
 (b)    any Originator shall fail to make when due any payment or deposit to be made by it under this
Agreement or any other Transaction Document to which it is a party and such failure shall remain unremedied for three (3) Business Days; 

(c)    any representation or warranty made or deemed to be made by any Originator (or any of its officers) under or in
connection with this Agreement, any other Transaction Documents to which it is a party, or any other information or report delivered 

  
 26 

 
pursuant hereto or thereto shall prove to have been incorrect or untrue in any material respect when made or deemed made or delivered; provided, that such circumstance shall not constitute
a Purchase and Sale Termination Event if such representation or warranty, or such information or report, is part of an Information Package, is corrected promptly (but not later than three (3) Business Days) after the Originator has knowledge or
receives notice thereof; provided, further that no breach of a representation or warranty set forth in Sections 5.5, 5.12, 5.20, 5.22, 5.23, 5.26 or 5.27 shall constitute a Purchase and
Sale Termination Event pursuant to this clause (c) if credit has been given for a reduction of the Purchase Price, the outstanding principal balance of the applicable Intercompany Loan has been reduced or the applicable Originator has
made a cash payment to the Buyer, in any case, as required pursuant to Section 3.3(c) with respect to such breach; 

(d)    any Originator shall fail to perform or observe any other term, covenant or agreement contained in this Agreement
or any other Transaction Document to which it is a party on its part to be performed or observed and such failure shall continue unremedied for thirty (30) days after the such Originator has knowledge or receives written notice thereof; or 

(e)    any Insolvency Proceeding shall be instituted against any Originator and such proceeding shall remain undismissed
or unstayed for a period of sixty (60) consecutive days or any of the actions sought in such proceeding (including the entry of an order for relief against, or the appointment of a receiver, trustee, custodian or other similar official for, it
or for any substantial part of its property) shall occur. 
 SECTION 8.2 Remedies. 

(a)    Optional Termination. Upon the occurrence and during the continuation of a Purchase and Sale Termination
Event, the Buyer (and not the Servicer), with the prior written consent of the Administrative Agent shall have the option, by notice to the Originators (with a copy to the Administrative Agent and the Lenders), to declare the Purchase Facility
terminated. 
 (b)    Remedies Cumulative. Upon any termination of the Purchase Facility pursuant to
Section 8.2(a), the Buyer (and the Administrative Agent as Buyer’s assignee) shall have, in addition to all other rights and remedies under this Agreement, all other rights and remedies provided under the UCC of each
applicable jurisdiction and other Applicable Laws, which rights shall be cumulative. 
 ARTICLE IX 

INDEMNIFICATION 
 SECTION 9.1
Indemnities by the Originators. Without limiting any other rights that the Buyer may have hereunder or under Applicable Law, each Originator and INC Research, jointly and severally, hereby agrees to indemnify the Buyer, each of its officers,
directors, employees, agents, employees and respective assigns, the Administrative Agent and each Lender (each of the foregoing Persons being individually called a “Purchase and Sale Indemnified Party”), forthwith on demand, from
and against any and all damages, claims, losses, judgments, liabilities, penalties and related costs and expenses (including Attorney Costs) (all of the foregoing being collectively 

  
 27 

 
called “Purchase and Sale Indemnified Amounts”) awarded against or incurred by any of them arising out of, relating to or in connection with: 

(a)    the breach of any representation or warranty made or deemed made by such Originator (or any employee, officer or
agent of such Originator) under or in connection with this Agreement or any of the other Transaction Documents, or any information or report delivered by or on behalf of such Originator pursuant hereto or thereto which shall have been untrue or
incorrect when made or deemed made or delivered; 
 (b)    the transfer by such Originator of any interest in any Pool
Receivable or Related Right other than the transfer of any Pool Receivable and Related Security to the Buyer pursuant to this Agreement and the grant of a security interest to the Buyer pursuant to this Agreement; 

(c)    the failure by such Originator to comply with the terms of any Transaction Document or with any Applicable Law with
respect to any Pool Receivable or the related Contract; or the failure of any Pool Receivable or the related Contract to conform to any such Applicable Law; 

(d)    the lack of an enforceable ownership interest, or a first priority perfected lien, in the Pool Receivables (and all
Related Security) originated by such Originator against all Persons (including any bankruptcy trustee or similar Person), in either case, free and clear of any Adverse Claim; 

(e)    the failure to have filed, or any delay in filing, financing statements, financing statement amendments,
continuation statements or other similar instruments or documents under the UCC of any applicable jurisdiction or other Applicable Laws with respect to any Pool Receivable or the Related Rights; 

(f)    any suit or claim related to the Pool Receivables originated by such Originator (including any products liability
or environmental liability claim arising out of or in connection with the property, products or services that are the subject of any Pool Receivable originated by such Originator); 

(g)    any dispute, claim, offset or defense (other than discharge in bankruptcy) of the Obligor to the payment of any
Receivable in the Receivables Pool (including a defense based on such Receivable’s or the related Contract’s not being a legal, valid and binding obligation of such Obligor enforceable against it in accordance with its terms) or any other
claim resulting from the sale of the property, products or services giving rise to such Receivable or the furnishing or failure to furnish such property, products or services; 

(h)    any failure of such Originator to perform any of its duties or obligations in accordance with the provisions hereof
and of each other Transaction Document related to Pool Receivables or to timely and fully comply with the Credit and Collection Policy in regard to each Pool Receivable; 

  
 28 

 (i)    any products liability, environmental or other claim arising out of or
in connection with any Receivable or other merchandise, goods or services which are the subject of or related to any Receivable; 

(j)    the commingling of Collections of Pool Receivables at any time with other funds; 

(k)    the failure or delay to provide any Obligor with an invoice or other evidence of indebtedness; 

(l)    any investigation, litigation or proceeding (actual or threatened) related to this Agreement or any other
Transaction Document or in respect of any Pool Receivable or any Related Rights; 
 (m)    any claim brought by any
Person other than a Purchase and Sale Indemnified Party arising from any activity by such Originator or any Affiliate of such Originator in servicing, administering or collecting any Pool Receivable; 

(n)    the failure by such Originator to pay when due any Taxes, including, without limitation, sales, excise or personal
property taxes; 
 (o)    any dispute, claim, offset or defense (other than discharge in bankruptcy of the Obligor) of
the Obligor to the payment of any Pool Receivable (including, without limitation, a defense based on such Pool Receivable or the related Contract not being a legal, valid and binding obligation of such Obligor enforceable against it in accordance
with its terms), or any other claim resulting from the sale of goods or the rendering of services related to such Pool Receivable or the furnishing or failure to furnish any such goods or services or other similar claim or defense not arising from
the financial inability of any Obligor to pay undisputed indebtedness; 
 (p)    any product liability claim arising out
of or in connection with goods or services that are the subject of any Receivable generated by such Originator; 

(q)    the failure or delay to provide any Obligor with an invoice or other evidence of indebtedness; 

(r)    any tax or governmental fee or charge, all interest and penalties thereon or with respect thereto, and all out-of-pocket costs and expenses, including without limitation Attorney Costs in defending against the same, which are required to be paid by reason of the purchase or
ownership of the Receivables generated by such Originator or any Related Rights connected with any such Receivables; 

(s)    any liability under Section 5.03 of the Receivables Financing Agreement; or 

(t)    any action taken by the Administrative Agent as
attorney-in-fact for such Originator pursuant to this Agreement or any other Transaction Document; 

  
 29 

 provided that such indemnity shall not be available to any Purchase and Sale Indemnified Party to the
extent that such losses, claims, damages, liabilities or related expenses (x) are determined by a court of competent jurisdiction in a final and nonappealable judgment to have resulted solely from the gross negligence or willful misconduct of a
Purchase and Sale Indemnified Party or (y) constitute recourse with respect to a Pool Receivable by reason of the bankruptcy or insolvency, or the financial or credit condition or financial default, of the related Obligor. 

Notwithstanding anything to the contrary in this Agreement, solely for purposes of such Originator’s indemnification obligations in this
Article IX, any representation, warranty or covenant qualified by the occurrence or non-occurrence of a material adverse effect or similar concepts of materiality shall be deemed to
be not so qualified. 
 If for any reason the foregoing indemnification is unavailable to any Purchase and Sale Indemnified Party or insufficient to hold it
harmless, then the Originators, jointly and severally, shall contribute to the amount paid or payable by such Purchase and Sale Indemnified Party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect
the relative economic interests of such Originator and its Affiliates, on the one hand, and such Purchase and Sale Indemnified Party, on the other hand, in the matters contemplated by this Agreement as well as the relative fault of such Originator
and its Affiliates and such Purchase and Sale Indemnified Party with respect to such loss, claim, damage or liability and any other relevant equitable considerations. The reimbursement, indemnity and contribution obligations of such Originator under
this Section shall be in addition to any liability which such Originator may otherwise have, shall extend upon the same terms and conditions to Purchase and Sale Indemnified Party, and shall be binding upon and inure to the benefit of any
successors, assigns, heirs and personal representatives of such Originator and the Purchase and Sale Indemnified Parties. Any indemnification or contribution under this Section shall survive the termination of this Agreement.  
 ARTICLE X 

MISCELLANEOUS 
 SECTION 10.1
Amendments, etc. 
 (a)    The provisions of this Agreement may from time to time be amended, modified or waived,
if such amendment, modification or waiver is in writing and executed by the Buyer, the Servicer and each Originator, with the prior written consent of the Administrative Agent and the Majority Lenders. 

(b)    No failure or delay on the part of the Buyer, the Servicer, any Originator, the Administrative Agent or any
third-party beneficiary in exercising any power or right hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power or right preclude any other or further exercise thereof or the exercise of any other
power or right. No notice to or demand on the Buyer, the Servicer or any Originator in any case shall entitle it to any notice or demand in similar or other circumstances. No waiver or approval by the Buyer, the Administrative Agent or the Servicer
under this Agreement shall, except as may otherwise be stated in such waiver or approval, be applicable to subsequent transactions. No waiver or approval under this Agreement shall require any similar or dissimilar waiver or approval thereafter to
be granted hereunder. 

  
 30 

 (c)    The Transaction Documents contain a final and complete integration of
all prior expressions by the parties hereto with respect to the subject matter thereof and shall constitute the entire agreement among the parties hereto with respect to the subject matter thereof, superseding all prior oral or written
understandings. 
 SECTION 10.2 Notices, etc. All notices and other communications provided for hereunder shall, unless otherwise stated
herein, be in writing (including facsimile or electronic mail communication) and shall be delivered or sent by facsimile, electronic mail, or by overnight mail, to the intended party at the mailing or electronic mail address or facsimile number of
such party set forth under its name on Schedule IV hereof or at such other address or facsimile number as shall be designated by such party in a written notice to the other parties hereto or in the case of the Administrative Agent or any
Lender, at their respective address for notices pursuant to the Receivables Financing Agreement. All such notices and communications shall be effective (i) if delivered by overnight mail, when received, and (ii) if transmitted by facsimile
or electronic mail, when sent, receipt confirmed by telephone or electronic means. 
 SECTION 10.3 No Waiver; Cumulative Remedies.
The remedies herein provided are cumulative and not exclusive of any remedies provided by law. Without limiting the foregoing, INC Research and each Originator hereby authorizes the Buyer, the Administrative Agent and each Lender (collectively, the
“Set-off Parties”), at any time and from time to time, to the fullest extent permitted by law, to set off, against any obligations of INC Research or such Originator to such Set-off Party arising in connection with the Transaction Documents (including, without limitation, amounts payable pursuant to Section 9.1) that are then due and payable or that are not
then due and payable but have accrued, any and all deposits (general or special, time or demand, provisional or final) at any time held by, and any and all indebtedness at any time owing by, any Set-off Party
to or for the credit or the account of INC Research or such Originator. 
 SECTION 10.4 Binding Effect; Assignability. This Agreement
shall be binding upon and inure to the benefit of the Buyer and each Originator and their respective successors and permitted assigns. No Originator may assign any of its rights hereunder or any interest herein without the prior written consent of
the Buyer, the Administrative Agent and each Lender, except as otherwise herein specifically provided. This Agreement shall create and constitute the continuing obligations of the parties hereto in accordance with its terms, and shall remain in full
force and effect until such time as the parties hereto shall agree. The rights and remedies with respect to any breach of any representation and warranty made by any Originator pursuant to Article V and the indemnification
and payment provisions of Article IX and Section 10.6 shall be continuing and shall survive any termination of this Agreement. 

SECTION 10.5 Governing Law. THIS AGREEMENT, INCLUDING THE RIGHTS AND DUTIES OF THE PARTIES HERETO, SHALL BE GOVERNED BY, AND CONSTRUED
IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BUT WITHOUT REGARD
TO ANY OTHER CONFLICTS OF LAW PROVISIONS THEREOF), EXCEPT TO THE EXTENT THAT THE 

  
 31 

 
PERFECTION OF A SECURITY INTEREST OR REMEDIES HEREUNDER, IN RESPECT OF ANY PARTICULAR COLLATERAL ARE GOVERNED BY THE LAWS OF A JURISDICTION OTHER THAN THE STATE OF NEW YORK. 

SECTION 10.6 Costs, Expenses and Taxes. In addition to the obligations of the Originators under Article IX, each Originator,
severally and for itself alone, and INC Research, jointly and severally with each Originator, agrees to pay on demand: 

(a)    to the Buyer (and any successor and permitted assigns thereof) and any third-party beneficiary of the Buyer’s
rights hereunder all reasonable out-of-pocket costs and expenses in connection with the preparation, negotiation, execution, delivery and administration of this
Agreement (together with all amendments, restatements, supplements, consents and waivers, if any, from time to time hereto), including, without limitation, (i) the reasonable Attorney Costs for the Buyer (and any successor and permitted assigns
thereof) and any third-party beneficiary of the Buyer’s rights hereunder with respect thereto and with respect to advising any such Person as to their rights and remedies under this Agreement and the other Transaction Documents and
(ii) reasonable accountants’, auditors’ and consultants’ fees and expenses for the Buyer (and any successor and permitted assigns thereof) and any third-party beneficiary of the Buyer’s rights hereunder incurred in
connection with the administration and maintenance of this Agreement or advising any such Person as to their rights and remedies under this Agreement or as to any actual or reasonably claimed breach of this Agreement or any other Transaction
Document; 
 (b)    to the Buyer (and any successor and permitted assigns thereof) and any third-party beneficiary of
the Buyer’s rights hereunder all reasonable out-of-pocket costs and expenses (including reasonable Attorney Costs), of any such Person incurred in connection with
the enforcement of any of their respective rights or remedies under the provisions of this Agreement and the other Transaction Documents; and 

(c)    all stamp, franchise and other taxes and fees payable in connection with the execution, delivery, filing and
recording of this Agreement or the other Transaction Documents to be delivered hereunder, and agrees to indemnify each Purchase and Sale Indemnified Party against any liabilities with respect to or resulting from any delay in paying or omitting to
pay such taxes and fees. 
 SECTION 10.7 SUBMISSION TO JURISDICTION. (a) EACH PARTY HERETO HEREBY IRREVOCABLY SUBMITS TO THE
EXCLUSIVE JURISDICTION OF ANY NEW YORK STATE OR FEDERAL COURT SITTING IN NEW YORK CITY, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT, AND EACH PARTY HERETO HEREBY IRREVOCABLY AGREES THAT ALL CLAIMS IN RESPECT OF
SUCH ACTION OR PROCEEDING SHALL BE HEARD AND DETERMINED IN SUCH NEW YORK STATE COURT OR, TO THE EXTENT PERMITTED BY LAW, IN SUCH FEDERAL COURT. THE PARTIES HERETO HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT THEY MAY EFFECTIVELY DO SO, THE
DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING. THE PARTIES HERETO AGREE THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT
OR IN ANY OTHER MANNER PROVIDED BY LAW. 

  
 32 

 (b)    EACH PARTY HERETO CONSENTS TO THE SERVICE OF ANY AND ALL PROCESS IN
ANY SUCH ACTION OR PROCEEDING BY THE MAILING OF COPIES OF SUCH PROCESS TO IT AT ITS ADDRESS SPECIFIED IN SCHEDULE IV. NOTHING IN THIS SECTION 10.7 SHALL AFFECT THE RIGHT OF THE PARTIES HERETO TO SERVE LEGAL PROCESS IN ANY OTHER MANNER
PERMITTED BY LAW. 
 SECTION 10.8 WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE MAXIMUM EXTENT PERMITTED BY
APPLICABLE LAW, TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER (WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS AGREEMENT OR ANY OTHER TRANSACTION
DOCUMENT. 
 SECTION 10.9 Captions and Cross References; Incorporation by Reference. The various captions (including, without
limitation, the table of contents) in this Agreement are included for convenience only and shall not affect the meaning or interpretation of any provision of this Agreement. References in this Agreement to any underscored Article, Section, Schedule
or Exhibit are to such Article, Section, Schedule or Exhibit of this Agreement, as the case may be. The Schedules and Exhibits hereto are hereby incorporated by reference into and made a part of this Agreement. 

SECTION 10.10 Execution in Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed
shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement. Delivery of an executed counterpart hereof by facsimile or other electronic means shall be equally effective as delivery of an
originally executed counterpart. 
 SECTION 10.11 Acknowledgment and Agreement. By execution below, each Originator expressly
acknowledges and agrees that all of the Buyer’s rights, title, and interests in, to, and under this Agreement (but not its obligations), shall be assigned by the Buyer to the Administrative Agent (for the benefit of the Lenders) pursuant to the
Receivables Financing Agreement, and each Originator consents to such assignment. Each of the parties hereto acknowledges and agrees that the Lenders and the Administrative Agent are third-party beneficiaries of the rights of the Buyer arising
hereunder and under the other Transaction Documents to which any Originator is a party, and notwithstanding anything to the contrary contained herein or in any other Transaction Document, during the occurrence and continuation of an Event of Default
under the Receivables Financing Agreement, the Administrative Agent, and not the Buyer, shall have the sole right to exercise all such rights and related remedies. 

SECTION 10.12 No Proceeding. Each Originator hereby agrees that it will not institute, or join any other Person in instituting, against
the Buyer any Insolvency Proceeding for at least one year and one day following the Final Payout Date. Each Originator further agrees that notwithstanding any provisions contained in this Agreement to the contrary, the Buyer shall not,

  
 33 

 
and shall not be obligated to, pay any amount in respect of any Intercompany Loan, any Intercompany Loan Agreement or otherwise to such Originator pursuant to this Agreement unless the Buyer has
received funds which may, subject to Section 4.01 of the Receivables Financing Agreement, be used to make such payment. Any amount which the Buyer does not pay pursuant to the operation of the preceding sentence shall not constitute a claim (as
defined in §101 of the Bankruptcy Code) against or corporate obligation of the Buyer by such Originator for any such insufficiency unless and until the provisions of the foregoing sentence are satisfied. The agreements in this
Section 10.12 shall survive any termination of this Agreement. 
 SECTION 10.13 Mutual Negotiations. This
Agreement and the other Transaction Documents are the product of mutual negotiations by the parties thereto and their counsel, and no party shall be deemed the draftsperson of this Agreement or any other Transaction Document or any provision hereof
or thereof or to have provided the same. Accordingly, in the event of any inconsistency or ambiguity of any provision of this Agreement or any other Transaction Document, such inconsistency or ambiguity shall not be interpreted against any party
because of such party’s involvement in the drafting thereof. 
 SECTION 10.14 Joint and Several Liability. Each of the
representations, warranties, covenants, obligations, indemnities and other undertakings of any Originator hereunder shall be made jointly and severally, and are joint and several liabilities of each of the Originators hereunder. 

SECTION 10.15 Severability. Any provisions of this Agreement which are prohibited or unenforceable in any jurisdiction shall, as to
such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction. 
 [Signature Pages Follow] 

  
 34 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their respective
officers thereunto duly authorized as of the date first above written. 
  

					
	SYNEOS HEALTH RECEIVABLES LLC,
	as Buyer
		
	By:	 	 /s/ Thomas E. Zajkowski

		 	Name:	 	Thomas E. Zajkowski
		 	Title:	 	President
	
	INC RESEARCH, LLC,
	as Servicer and as an Originator
		
	By:	 	 /s/ Jason Meggs

		 	Name:	 	Jason Meggs
		 	Title:	 	Chief Financial Officer
	
	INVENTIV HEALTH CLINICAL, LLC,
	as an Originator
		
	By:	 	 /s/ Thomas E. Zajkowski

		 	Name:	 	Thomas E. Zajkowski
		 	Title:	 	Treasurer

  

					
		 	S-1	 	Purchase and Sale Agreement

 Schedule I 

LIST AND LOCATION OF EACH ORIGINATOR 
  

					
	 Originator
	  	Location	 
	 INC Research, LLC
	  	 	Delaware	 
	 inVentiv Health Clinical, LLC
	  	 	Delaware	 

  

					
		 	Schedule I-1	 	Purchase and Sale Agreement

 Schedule II 

LOCATION OF BOOKS AND RECORDS OF ORIGINATORS 
  

					
	 Originator
	  	Location of Books and Records	 
	 INC Research, LLC
	  	 	3201 Beechleaf Court, Suite 600, Raleigh, NC 27604	 
	 inVentiv Health Clinical, LLC
	  	 	3201 Beechleaf Court, Suite 600, Raleigh, NC 27604	 

  

					
		 	Schedule II-1	 	Purchase and Sale Agreement

 Schedule III 

TRADE NAMES 
 INC Research, LLC

 Syneos Health has been used as a trade name since January 4, 2018. 

INC Research LLC has qualified to do business in the State of California under the name “Integrated Neurosciences Consortium, LLC”.

 inVentiv Health Clinical, LLC 

Syneos Health has been used as a trade name since January 4, 2018. 

  

					
		 	Schedule III-1	 	Purchase and Sale Agreement

 Schedule IV 

NOTICE ADDRESSES 
 If to INC Research,
LLC: 
 INC Research, LLC 
 c/o Syneos Health, Inc. 

3201 Beechleaf Court, Suite 600 
 Raleigh, NC 27604 

Attention: General Counsel 
 with a copy to: 

Wyrick Robbins Yates & Ponton LLP 
 4101 Lake Boone
Trail, Suite 300 
 Raleigh, NC 27607 
 Attention: Carolyn W.
Minshall, Esq. 
 If to inVentiv Health Clinical, LLC: 

inVentiv Health Clinical, LLC 
 c/o Syneos Health, Inc. 

3201 Beechleaf Court, Suite 600 
 Raleigh, NC 27604 

Attention: General Counsel 
 with a copy to: 

Wyrick Robbins Yates & Ponton LLP 
 4101 Lake Boone
Trail, Suite 300 
 Raleigh, NC 27607 
 Attention: Carolyn W.
Minshall, Esq. 

  

					
		 	Schedule IV-1	 	Purchase and Sale Agreement

 Schedule V 

ACTIONS/SUITS 
 None 

  

					
		 	Schedule V-1	 	Purchase and Sale Agreement

 Exhibit A 

FORM OF PURCHASE REPORT 
  

			
		
	Originator:	  	[Name of Originator]
		
	Buyer:	  	Syneos Health Receivables LLC
		
	Payment Date:	  	             , 20    

  

	1.	Outstanding Balance of Receivables [Purchased] [Contributed to the Capital of Buyer] [on the Closing Date][during the preceding calendar month]: 

 

	2.	[Fair Market Value Discount: 

 1/{1 + (Prime Rate x Days’ Sales Outstanding} 

                     
                   365     

Where: 
 Prime
Rate    =                     

Days’ Sales Outstanding    =             ]

  

	3.	Purchase Price (1 x 2) = $              

  

	4.	Reductions in the Purchase Price = $              

  

	5.	Net Purchase Price (3 – 4) = $              

  

					
		 	Exhibit A-1	 	Purchase and Sale Agreement

 Exhibit B 

FORM OF INTERCOMPANY LOAN AGREEMENT 

This Intercompany Loan Agreement (this “Loan Agreement”), is dated as of
[            ], 20[    ], by and between Syneos Health Receivables LLC, a Delaware limited liability company (the “Borrower”), and
[                    ], a
[                    ] (the “Intercompany Lender”). 

W I T N E S S E T H: 

WHEREAS, this Loan Agreement is one of the Intercompany Loan Agreements described in, and is subject to the terms and conditions set forth in,
that certain Purchase and Sale Agreement, dated as of June 29, 2018 (as the same may be amended, restated, supplemented or otherwise modified from time to time, the “Purchase and Sale Agreement”), among the Borrower, INC
Research, LLC, a Delaware corporation, as Servicer, the Intercompany Lender, and the other originators from time to time party thereto; 

WHEREAS, pursuant to the Purchase and Sale Agreement, from the date hereof until the Purchase and Sale Termination Date, the Borrower will be
purchasing from the Intercompany Lender, Receivables and Related Rights that are generated by the Intercompany Lender; 
 WHEREAS, the
Borrower desires from time to time to borrow funds from the Intercompany Lender (each, an “Intercompany Loan”) according to the terms and conditions set forth herein and in the Purchase and Sale Agreement to pay all or a portion of
the Purchase Price owing by the Borrower to the Intercompany Lender in connection with the Receivables and Related Rights purchased by the Borrower from the Intercompany Lender in accordance with the Purchase and Sale Agreement; and 

WHEREAS, the Intercompany Lender agrees from time to time to make Intercompany Loans to the Borrower on the terms and conditions set forth
herein and in the Purchase and Sale Agreement. 
 NOW THEREFORE, the parties agree as follows: 

1.    Definitions. Capitalized terms used (but not defined) herein have the meanings assigned thereto in the
Purchase and Sale Agreement and in Article I of the Receivables Financing Agreement (as defined in the Purchase and Sale Agreement). In addition, as used herein, the following terms have the following meanings: 

“AFR” shall mean the rate published in connection with Treas. Reg.
Section 1.482-2(a)(2)(iii) (or any successor thereto or replacement thereto). 

“Bankruptcy Proceedings” has the meaning set forth in clause (b) of paragraph 9 hereof.

  

					
		 	Exhibit B-1	 	Purchase and Sale Agreement

 “Senior Interest Holders” means, collectively, the Lenders, the
Administrative Agent, the Borrower Indemnified Parties, the Servicer Indemnified Parties and the Affected Persons. 

“Senior Interests” means, collectively, (i) the Aggregate Interest, (ii) the Aggregate Capital,
(iii) the fees referred to in Section 2.03 of the Receivables Financing Agreement, (iv) all amounts payable pursuant to Sections 5.01, 5.02, 5.03, 13.01, 13.02 or 14.04 of
the Receivables Financing Agreement and (v) all other obligations of the Borrower and the Servicer that are due and payable, to (a) the Lenders, the Administrative Agent and their respective successors, permitted transferees and assigns
arising in connection with the Transaction Documents and (b) any Borrower Indemnified Party, Servicer Indemnified Party or Affected Person arising in connection with the Receivables Financing Agreement or any other Transaction Document, in each
case, howsoever created, arising or evidenced, whether direct or indirect, absolute or contingent, now or hereafter existing, or due or to become due, together with any and all interest accruing on any such amount after the commencement of any
Bankruptcy Proceedings, notwithstanding any provision or rule of law that might restrict the rights of any Senior Interest Holder, as against the Borrower or anyone else, to collect such interest. 

“Subordination Provisions” means, collectively, clauses (a) through (l) of paragraph
9 hereof. 
 2.    Intercompany Loan Facility. 

(a)    Commitment. Subject to the terms and conditions of this Loan Agreement and the Purchase and
Sale Agreement, the Intercompany Lender hereby agrees to make Intercompany Loans to the Borrower, on each Payment Date prior to the Purchase and Sale Termination Date, in the aggregate amount of the unpaid Purchase Price for Receivables and Related
Rights that were generated by the Intercompany Lender and owing by the Borrower to the Intercompany Lender on such date. 

(b)    Making Loans. An Intercompany Loan shall be deemed to have been made on each Payment Date in
the aggregate amount of the unpaid Purchase Price owing by the Borrower to the Intercompany Lender on such date and determined pursuant to Section 3.2(c) of the Purchase and Sale Agreement, in each case, without any further action or notice on
the part of the Borrower, the Intercompany Lender or any other Person; provided, however, that no Intercompany Loan shall be made by the Intercompany Lender on any Payment Date if the Buyer’s Net Worth would be less than the Required Capital
Amount after giving effect thereto. Additionally, no Intercompany Loan may be made by the Intercompany Lender to the Borrower for any other purpose. 

3.    Records. The Intercompany Lender is authorized and directed by the Borrower to enter in its books and records
(or in the books and records of the Servicer), the date and amount of each Intercompany Loan made by the Intercompany Lender and the amount of each payment of principal made by the Borrower on such Intercompany Loan. Absent manifest error, such
entries shall constitute prima facie evidence of the accuracy of the information so entered; provided that neither the failure of the Intercompany Lender or the Servicer to make any such entry nor any error therein shall expand, limit or
affect the obligations of the Borrower hereunder. 

  

					
		 	Exhibit B-2	 	Purchase and Sale Agreement

 4.    Interest. The Borrower agrees to pay interest on the outstanding
principal amount of each Intercompany Loan from the date on which such Intercompany Loan has been made to the date on which such amount is repaid in full at a rate per annum equal to AFR. Interest accrued hereunder shall be computed
for the actual number of days elapsed on the basis of a 365- or 366-day year, as the case may be. 

5.    Interest Payment Dates. Subject to the Subordination Provisions set forth below, the Borrower shall pay
accrued interest on the outstanding principal amount of each Intercompany Loan on each Monthly Settlement Date, and shall pay accrued interest on the amount of each principal payment made in cash on a date other than a Monthly Settlement Date at the
time of such principal payment. 
 6.    Principal Payment Dates. Subject to the Subordination Provisions set
forth below, payments of the principal amount of the Intercompany Loans shall be made as follows: 

(a)    The principal amount of the Intercompany Loans shall be reduced by an amount equal to each payment
deemed made pursuant to Section 3.3 of the Purchase and Sale Agreement. 

(b)    The entire outstanding principal amount of all Intercompany Loans shall be due on the Final Payout
Date. 
 (c)    The principal amount of and accrued interest on the Intercompany Loans may be prepaid by,
and in the sole discretion of the Borrower, on any Business Day without premium or penalty. 
 7.    Payment
Mechanics. All payments of principal and interest hereunder are to be made in lawful money of the United States of America in the manner specified in Article III of the Purchase and Sale Agreement. 

8.    Enforcement Expenses. In addition to and not in limitation of the foregoing, but subject to the Subordination
Provisions set forth below and to any limitation imposed by Applicable Law, the Borrower agrees to pay all expenses, including Attorney Costs, incurred by the Intercompany Lender in seeking to collect any amounts payable hereunder which are not paid
when due. 
 9.    Subordination Provisions. The Borrower covenants and agrees, and the Intercompany Lender and
any other assignee, transferee or pledgee of this Loan Agreement or any Intercompany Loans (collectively, the Intercompany Lender and any such other assignee, transferee or pledgee are called the “Holder”), by its acceptance of any
sale, assignment, transfer or pledge of this Loan Agreement or any Intercompany Loans, likewise covenants and agrees on behalf of itself and any Holder, that the payment of the principal amount of and interest on the Intercompany Loans and any other
payments owing under this Loan Agreement are hereby 

  

					
		 	Exhibit B-3	 	Purchase and Sale Agreement

 
expressly subordinated in right of payment to the payment and performance of the Senior Interests to the extent and in the manner set forth in the following clauses of this
paragraph 9: 
 (a)    No payment or other distribution of the Borrower’s
assets of any kind or character, whether in cash, securities, or other rights or property, shall be made on account of this Loan Agreement or any Intercompany Loan except to the extent such payment or other distribution is either (i) permitted
under Section 8.01(r) of the Receivables Financing Agreement or (ii) made on or after the Final Payout Date; 

(b)    In the event of any dissolution, winding up, liquidation, readjustment, reorganization or other
similar event relating to the Borrower, whether voluntary or involuntary, partial or complete, and whether in bankruptcy, insolvency or receivership proceedings, or upon an assignment for the benefit of creditors, or any other marshalling of the
assets and liabilities of the Borrower or any sale of all or substantially all of the assets of the Borrower other than as permitted by the Purchase and Sale Agreement (such proceedings being herein collectively called “Bankruptcy
Proceedings”), the Senior Interests shall first be paid and performed in full and in cash before the Holder shall be entitled to receive and to retain any payment or distribution in respect of this Loan Agreement or any Intercompany Loan.
In order to implement the foregoing: (i) all payments and distributions of any kind or character in respect of this Loan Agreement or any Intercompany Loan to which the Holder would be entitled except for this clause (b) shall be
made directly to the Administrative Agent (for the benefit of the Senior Interest Holders); (ii) the Holder shall promptly file a claim or claims, in the form required in any Bankruptcy Proceedings, for the full outstanding amount owed under this
Loan Agreement (and if the Holder does not promptly do so, the Administrative Agent may), and shall use commercially reasonable efforts to cause said claim or claims to be approved and all payments and other distributions in respect thereof to be
made directly to the Administrative Agent (for the benefit of the Senior Interest Holders) until the Senior Interests shall have been paid and performed in full and in cash; and (iii) the Holder hereby irrevocably agrees that the Administrative
Agent (acting on behalf of the Lenders), may in the name of the Holder or otherwise, demand, sue for, collect, receive and receipt for any and all such payments or distributions, and file, prove and vote or consent in any such Bankruptcy Proceedings
with respect to any and all claims of the Holder relating to this Loan Agreement or any Intercompany Loan, in each case until the Senior Interests shall have been paid and performed in full and in cash; 

(c)    In the event that the Holder receives any payment or other distribution of any kind or character
from the Borrower or from any other source whatsoever, in respect of this Loan Agreement or any Intercompany Loan, other than as expressly permitted by the terms of this Loan Agreement, such payment or other distribution shall be received in trust
for the Senior Interest Holders and shall be turned over by the Holder to the Administrative Agent (for the benefit of the Senior Interest Holders) forthwith. The Holder will mark its books and records so as clearly to indicate that this Loan
Agreement and the Intercompany Loans are subordinated in accordance with the terms hereof. All payments and distributions received by the Administrative Agent in respect of this Loan Agreement or any Intercompany Loan, to the extent received in or
converted into cash, may be applied by the Administrative Agent (for the benefit of the Senior Interest 

  

					
		 	Exhibit B-4	 	Purchase and Sale Agreement

 
Holders) first to the payment of any and all expenses (including Attorney Costs) paid or incurred by the Senior Interest Holders in enforcing these Subordination Provisions, or in endeavoring to
collect or realize upon this Loan Agreement and the Intercompany Loans, and any balance thereof shall, solely as between the Intercompany Lender and the Senior Interest Holders, be applied by the Administrative Agent (in the order of application set
forth in Section 4.01(a) of the Receivables Financing Agreement) toward the payment of the Senior Interests; but as between the Borrower and its creditors, no such payments or distributions of any kind or character shall be
deemed to be payments or distributions in respect of the Senior Interests; 
 (d)    Notwithstanding any
payments or distributions received by the Senior Interest Holders in respect of this Loan Agreement or any Intercompany Loan, while any Bankruptcy Proceedings are pending the Holder shall not be subrogated to the then existing rights of the Senior
Interest Holders in respect of the Senior Interests until the Senior Interests have been paid and performed in full and in cash. If no Bankruptcy Proceedings are pending, the Holder shall only be entitled to exercise any subrogation rights that it
may acquire (by reason of a payment or distribution to the Senior Interest Holders in respect of this Loan Agreement or any Intercompany Loan) to the extent that any payment arising out of the exercise of such rights would be permitted under
Section 8.01 (r) of the Receivables Financing Agreement; 
 (e)    These
Subordination Provisions are intended solely for the purpose of defining the relative rights of the Holder, on the one hand, and the Senior Interest Holders on the other hand. Nothing contained in these Subordination Provisions or elsewhere in this
Loan Agreement is intended to or shall impair, as between the Borrower, its creditors (other than the Senior Interest Holders) and the Holder, the Borrower’s obligation, which is unconditional and absolute, to pay the Holder the principal of
and interest on the Intercompany Loans as and when the same shall become due and payable in accordance with the terms hereof or to affect the relative rights of the Holder and creditors of the Borrower (other than the Senior Interest Holders); 

(f)    The Holder shall not, until the Senior Interests have been paid and performed in full and in cash,
(i) cancel, waive, forgive, transfer or assign, or commence legal proceedings to enforce or collect, or subordinate to any obligation of the Borrower, howsoever created, arising or evidenced, whether direct or indirect, absolute or contingent,
or now or hereafter existing, or due or to become due, other than the Senior Interests, this Loan Agreement or any rights in respect hereof or (ii) convert this Loan Agreement or any Intercompany Loan into an equity interest in the Borrower,
unless the Holder shall, in either case, have received the prior written consent of the Administrative Agent; 

(g)    The Holder shall not, without the advance written consent of the Administrative Agent and each
Lender, commence, or join with any other Person in commencing, any Bankruptcy Proceedings with respect to the Borrower until at least one year and one day shall have passed since the Final Payout Date; 

  

					
		 	Exhibit B-5	 	Purchase and Sale Agreement

 (h)    If, at any time, any payment (in whole or in part) of
any Senior Interest is rescinded or must be restored or returned by a Senior Interest Holder (whether in connection with Bankruptcy Proceedings or otherwise), these Subordination Provisions shall continue to be effective or shall be reinstated, as
the case may be, as though such payment had not been made; 
 (i)    Each of the Senior Interest Holders
may, from time to time, at its sole discretion, without notice to the Holder, and without waiving any of its rights under these Subordination Provisions, take any or all of the following actions: (i) retain or obtain an interest in any property
to secure any of the Senior Interests; (ii) retain or obtain the primary or secondary obligations of any other obligor or obligors with respect to any of the Senior Interests; (iii) extend or renew for one or more periods (whether or not
longer than the original period), alter or exchange any of the Senior Interests, or release or compromise any obligation of any nature with respect to any of the Senior Interests; (iv) amend, supplement, amend and restate, or otherwise modify
any Transaction Document; and (v) release its security interest in, or surrender, release or permit any substitution or exchange for all or any part of any rights or property securing any of the Senior Interests, or extend or renew for one or
more periods (whether or not longer than the original period), or release, compromise, alter or exchange any obligations of any nature of any obligor with respect to any such rights or property; 

(j)    The Holder hereby waives: (i) notice of acceptance of these Subordination Provisions by any of
the Senior Interest Holders; (ii) notice of the existence, creation, non-payment or non-performance of all or any of the Senior Interests; and (iii) all
diligence in enforcement, collection or protection of, or realization upon, the Senior Interests, or any thereof, or any security therefor; 

(k)    Each of the Senior Interest Holders may, from time to time, on the terms and subject to the
conditions set forth in the Transaction Documents to which such Persons are party, but without notice to the Holder, assign or transfer any or all of the Senior Interests, or any interest therein; and, notwithstanding any such assignment or transfer
or any subsequent assignment or transfer thereof, such Senior Interests shall be and remain Senior Interests for the purposes of these Subordination Provisions, and every immediate and successive assignee or transferee of any of the Senior Interests
or of any interest of such assignee or transferee in the Senior Interests shall be entitled to the benefits of these Subordination Provisions to the same extent as if such assignee or transferee were the assignor or transferor; and 

(l)    These Subordination Provisions constitute a continuing offer from the Holder to all Persons who
become the holders of, or who continue to hold, Senior Interests; and these Subordination Provisions are made for the benefit of the Senior Interest Holders, and the Administrative Agent may proceed to enforce such provisions on behalf of each of
such Persons. 
 10.    General. No failure or delay on the part of the Intercompany Lender in exercising any
power or right hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power or right preclude any other or further exercise thereof or the exercise 

  

					
		 	Exhibit B-6	 	Purchase and Sale Agreement

 
of any other power or right. No amendment, restatement, modification or waiver of, or consent with respect to, any provision of this Loan Agreement shall in any event be effective unless
(i) the same shall be in writing and signed and delivered by the Borrower, the Holder and the Administrative Agent and (ii) all consents required for such actions under the Transaction Documents shall have been received by the appropriate
Persons. 
 11.    Maximum Interest. Notwithstanding anything in this Loan Agreement to the contrary, the
Borrower shall never be required to pay unearned interest on any amount outstanding hereunder and shall never be required to pay interest on the outstanding principal amount of the Intercompany Loans at a rate in excess of the maximum nonusurious
interest rate that may be contracted for, charged or received under applicable federal or state law (such maximum rate being herein called the “Highest Lawful Rate”). If the effective rate of interest which would otherwise be
payable under this Loan Agreement would exceed the Highest Lawful Rate, or if the Holder shall receive any unearned interest or shall receive monies that are deemed to constitute interest which would increase the effective rate of interest payable
by the Borrower under this Loan Agreement to a rate in excess of the Highest Lawful Rate, then (i) the amount of interest which would otherwise be payable by the Borrower under this Loan Agreement shall be reduced to the amount allowed by
Applicable Law and (ii) any unearned interest paid by the Borrower or any interest paid by the Borrower in excess of the Highest Lawful Rate shall be refunded to the Borrower. Without limitation of the foregoing, all calculations of the rate of
interest contracted for, charged or received by the Holder under this Loan Agreement that are made for the purpose of determining whether such rate exceeds the Highest Lawful Rate applicable to the Intercompany Lender (such Highest Lawful Rate being
herein called the “Maximum Permissible Rate”) shall be made, to the extent permitted by usury laws applicable to the Holder (now or hereafter enacted), by amortizing, prorating and spreading in equal parts during the actual period
during which any amount has been outstanding hereunder all interest at any time contracted for, charged or received by the Holder in connection herewith. If at any time and from time to time (i) the amount of interest payable to the Holder on
any date shall be computed at the Maximum Permissible Rate pursuant to the provisions of the foregoing sentence and (ii) in respect of any subsequent interest computation period the amount of interest otherwise payable to the Holder would be
less than the amount of interest payable to the Holder computed at the Maximum Permissible Rate, then the amount of interest payable to the Holder in respect of such subsequent interest computation period shall continue to be computed at the Maximum
Permissible Rate until the total amount of interest payable to the Holder shall equal the total amount of interest which would have been payable to the Holder if the total amount of interest had been computed without giving effect to the provisions
of the foregoing sentence. 
 12.    Assignability. The Intercompany Lender may not sell, transfer, assign (by
operation of law or otherwise) or otherwise dispose of, or grant any option with respect to, or create or suffer to exist any Adverse Claim upon (including, without limitation, the filing of any financing statement) or with respect to, this Loan
Agreement or any Intercompany Loan, without the prior written consent of the Administrative Agent. 

13.    GOVERNING LAW. THIS LOAN AGREEMENT, INCLUDING THE RIGHTS AND DUTIES OF THE PARTIES HERETO, SHALL
BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF
NEW YORK, BUT WITHOUT REGARD TO ANY OTHER CONFLICTS OF LAW PROVISIONS THEREOF). 

  

					
		 	Exhibit B-7	 	Purchase and Sale Agreement

 14.    SUBMISSION TO JURISDICTION. EACH PARTY HERETO HEREBY
IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF ANY NEW YORK STATE OR FEDERAL COURT SITTING IN NEW YORK CITY, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS LOAN AGREEMENT, AND EACH PARTY HERETO HEREBY IRREVOCABLY
AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING SHALL BE HEARD AND DETERMINED IN SUCH NEW YORK STATE COURT OR, TO THE EXTENT PERMITTED BY LAW, IN SUCH FEDERAL COURT.  

15.    Execution in Counterparts. This Loan Agreement may be executed in any number of counterparts, each of which
when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement. Delivery of an executed counterpart hereof by facsimile or other electronic means shall be equally effective as
delivery of an originally executed counterpart. 
 16.    Captions. Paragraph captions used in this Loan
Agreement are for convenience only and shall not affect the meaning or interpretation of any provision of this Loan Agreement. 

  

					
		 	Exhibit B-8	 	Purchase and Sale Agreement

 IN WITNESS WHEREOF, the parties have caused this Loan Agreement to be executed by their
respective officers thereunto duly authorized as of the date first above written. 
  

			
	SYNEOS HEALTH RECEIVABLES LLC, as Borrower
		
	By:	 	
                     
                                         
          

	Name:	 	  

	Title:	 	  

	
	[                                   
             ],
	as Lender
		
	By:	 	
                     
                                

	Name:	 	  

	Title:	 	  

  

					
		 	Exhibit B-9	 	Purchase and Sale Agreement

 Exhibit C 

FORM OF JOINDER AGREEMENT 

THIS JOINDER AGREEMENT, dated as of             ,
20[    ] (this “Agreement”) is executed by                     , a
                     organized under the laws of
                     (the “Additional Originator”), with its principal place of business located at
                    . 

BACKGROUND: 

A.    Syneos Health Receivables LLC, a Delaware limited liability company (the “Buyer”), INC Research
LLC, a Delaware limited liability company, as initial Servicer, and the various entities from time to time party thereto, as Originators (collectively, the “Originators”), have entered into that certain Purchase and Sale Agreement,
dated as of June 29, 2018 (as amended, restated, supplemented or otherwise modified through the date hereof, and as it may be further amended, restated, supplemented or otherwise modified from time to time, the “Purchase and Sale
Agreement”). 
 B.    The Additional Originator desires to become an Originator pursuant to
Section 4.3 of the Purchase and Sale Agreement. 
 NOW, THEREFORE, in consideration of the foregoing and other
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Additional Originator hereby agrees as follows: 

SECTION 1.    Definitions. Capitalized terms used in this Agreement and not otherwise defined herein shall have the
meanings assigned thereto in the Purchase and Sale Agreement or in the Receivables Financing Agreement (as defined in the Purchase and Sale Agreement). 

SECTION 2.    Transaction Documents. The Additional Originator hereby agrees that it shall be bound by all of the
terms, conditions and provisions of, and shall be deemed to be a party to (as if it were an original signatory to), the Purchase and Sale Agreement and each of the other relevant Transaction Documents. From and after the later of the date hereof and
the date that the Additional Originator has complied with all of the requirements of Section 4.3 of the Purchase and Sale Agreement, the Additional Originator shall be an Originator for all purposes of the Purchase and Sale
Agreement and all other Transaction Documents. The Additional Originator hereby acknowledges that it has received copies of the Purchase and Sale Agreement and the other Transaction Documents. 

SECTION 3.    Representations and Warranties. The Additional Originator hereby makes all of the representations and
warranties set forth in Article V (to the extent applicable) of the Purchase and Sale Agreement as of the date hereof (unless such representations or warranties relate to an earlier date, in which case as of such earlier date), as if such
representations and warranties were fully set forth herein. The Additional Originator hereby represents and warrants that its “location” (as defined in the applicable UCC) is
[                    ], and the 

  

					
		 	Exhibit C-1	 	Purchase and Sale Agreement

 
offices where the Additional Originator keeps all of its books and records concerning the Receivables and Related Security is as follows: 

 

                       
                                      

                       
                                      

                       
                                      

SECTION 4.    Miscellaneous. This Agreement, including the rights and duties of the parties hereto, shall be
governed by, and construed in accordance with, the laws of the State of New York (including Sections 5-1401 and 5-1402 of the General Obligations Law of the State of New
York, but without regard to any other conflicts of law provisions thereof). This Agreement is executed by the Additional Originator for the benefit of the Buyer, and its assigns, and each of the foregoing parties may rely hereon. This Agreement
shall be binding upon, and shall inure to the benefit of, the Additional Originator and its successors and permitted assigns. 
 [Signature
Pages Follow] 

  

					
		 	Exhibit C-2	 	Purchase and Sale Agreement

 IN WITNESS WHEREOF, the undersigned has caused this Agreement to be executed by its duly
authorized officer as of the date and year first above written. 
  

			
	[NAME OF ADDITIONAL ORIGINATOR]
		
	By:	 	
                     
                                         
                       

		 	Name:
		 	Title:

  

					
	Consented to:
	
	SYNEOS HEALTH RECEIVABLES LLC
		
	By:	 	
                     
                                        

		 	Name:	 	
                     
                    

		 	Title:	 	
                     
                    

	
	Acknowledged by:
	
	PNC BANK, NATIONAL ASSOCIATION as Administrative Agent
		
	By:	 	
                     
                                        

		 	Name:	 	
                     
                    

		 	Title:	 	  

	
	[LENDERS]
		
	By:	 	  

		 	Name:	 	  

		 	Title:	 	  

	
	INC RESEARCH, LLC
		
	By:	 	
                     
                                        

		 	Name:	 	
                     
                                        

		 	Title:	 	
                     
                    

  

					
		 	Exhibit C-3	 	Purchase and Sale AgreementExhibit 10.1

 

RETIREMENT AGREEMENT

 

This Retirement Agreement (the “Agreement”) is made as of the Agreement Effective Date (as defined below) by and between Voyager Therapeutics, Inc. (the “Company”) and Steven M. Paul (“Executive”) (together, the “Parties”).

 

WHEREAS, the Company and Executive are parties to the Employment Agreement dated as of May 11, 2016 (the “Employment Agreement”), under which Executive currently serves as President and Chief Executive Officer of the Company;

 

WHEREAS, Executive has notified the Company of his desire to retire from the Company, and the Parties mutually have agreed to establish terms for Executive’s separation from employment with the Company; and

 

WHEREAS, the Parties agree that the payments, benefits and rights set forth in this Agreement shall be the exclusive payments, benefits and rights due Executive in connection with his retirement and separation from employment with the Company;

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

 

1.                                      Retirement Date; Resignation from Position(s); Transition Period —

 

(a)  Executive’s effective date of retirement and separation from employment with the Company will be August 1, 2018, such earlier date as may be mutually agreed upon by the Company and Executive, or such earlier date as the Company’s Board of Directors (the “Board”) may designate (the “Retirement Date”).  Executive hereby resigns (i) as of July 16, 2018 (or such earlier date that any other individual commences employment as the Company’s President and/or Chief Executive Officer), from his positions as President and Chief Executive Officer of the Company, and (ii) as of the Retirement Date, from any and all other positions he holds as an officer or employee of the Company, and further agrees to execute and deliver any documents reasonably necessary to effectuate such resignations, as requested by the Company.  As of the Agreement Effective Date, the Employment Agreement will terminate and be of no further force or effect; provided, however, that Executive’s Confidentiality, Noncompetition and Assignment Agreement dated June 16, 2015 and referenced in the Employment Agreement (the “Restrictive Covenants Agreement”) shall remain in full force and effect both during the Transition Period (as defined below) and thereafter.  Notwithstanding the foregoing, the Company retains the right to terminate Executive’s employment prior to the Retirement Date for Cause (as defined in the Employment Agreement).

 

(b)  The period between the Agreement Effective Date and the Retirement Date will be a transition period (the “Transition Period”). During the Transition Period, Executive will continue to perform  on a full-time basis those duties consistent with his position and use his best efforts to professionally, timely and cooperatively perform such duties, as well as such additional transition duties as may be requested by and at the direction of the Board, including, without limitation, assisting with the transition of his duties and responsibilities to any individual hired by the Company to assume Executive’s responsibilities, including any individual hired in the role of President and/or Chief Executive Officer (collectively, the “Transition Duties”).  Notwithstanding the foregoing, however, Executive will not be required to come into the office on a full time basis after July 16, 2018, but shall remain available thereafter and until the Retirement Date, upon request by the Company, to come into the office and/or to provide information or answer questions by

 

1

 

telephone or email related to his employment with the Company and/or the transition of his duties. During the Transition Period, Executive will continue to receive his current base salary, to participate in the Company’s benefit plans (pursuant to the terms and conditions of such plans) and to be entitled to vacation time in accordance with Company policy.

 

(c)  Upon Executive’s last day of employment with the Company, Executive shall be paid, in accordance with the Company’s regular payroll practices, all unpaid base salary earned through such date, including any amounts for accrued unused vacation time to which Executive is entitled through such date in accordance with Company policy, and reimbursement of any properly incurred unreimbursed business expenses incurred through the Retirement Date (together, the “Accrued Obligations”).  As of Executive’s last day of employment, all salary payments from the Company will cease and any benefits Executive had as of such date under Company-provided benefit plans, programs, or practices will terminate, except as required by federal or state law or as otherwise specifically set forth in this Agreement.

 

2.                                      Retirement Benefit — In consideration of Executive’s entering into and abiding by the commitments and obligations set forth in this Agreement, and provided Executive (i) signs and returns this Agreement on or before July 2, 2018, (ii) continues employment through the Retirement Date in accordance with the terms hereof, (iii) signs and returns the Additional Release of Claims attached hereto as Attachment A (the “Additional Release”) on but not before the Retirement Date (provided, however, that if the Retirement Date is fewer than twenty-one (21) days following the Receipt Date (as defined below), Executive must sign and return the Additional Release no earlier than the Retirement Date and no later than the 22nd day after the Receipt Date) and does not timely revoke such Additional Release, and (iv) complies with the terms of this Agreement, the Additional Release and the Restrictive Covenants Agreement, the Company will provide Executive with the following retirement benefit (the “Retirement Benefit”):  (i) each restricted stock award granted by the Company to Executive shall continue to vest and become free from repurchase, forfeiture provisions and restrictions on transfer during the three-year period following the Retirement Date (the “Three-Year Post-Retirement Period”) on the same schedule and terms, and subject to the same conditions, as set forth in each applicable restricted stock agreement, as if Executive had continued to remain employed during the Three-Year Post-Retirement Period and (ii) each stock option granted by the Company to Executive shall continue to vest and become exercisable during the Three-Year Post-Retirement Period on the same schedule and terms, and subject to the same conditions, as set forth in each applicable option agreement as if Executive had continued to remain employed during the Three-Year Post-Retirement Period and Executive shall have three months from the end of the Three-Year Post-Retirement Period to exercise any stock options that have vested and become exercisable as of such date.  Executive agrees and acknowledges that by virtue of the extension of the post-termination exercise period for Executive’s stock options provided for in the previous sentence, any stock options that were intended to be “incentive stock options” under Section 422 of the Internal Revenue Code, as amended, shall, as of the Agreement Effective Date, be treated as, and taxable as, non-qualified stock options for all tax purposes.

 

Other than the Retirement Benefit and Accrued Obligations, Executive will not be eligible for, nor shall he have a right to receive, any payments or benefits from the Company following the Retirement Date. For the avoidance of doubt, Executive acknowledges that he is not eligible for or entitled to receive any severance benefits pursuant to the Employment Agreement, and further acknowledges that he will not be eligible to receive the Retirement Benefit (or any payments or benefits from the Company other than the Accrued Obligations) if he fails to timely enter into this Agreement and the Additional Release or if his employment is terminated for Cause prior to the Retirement Date or if he fails to comply with his obligations under this Agreement or the Restrictive Covenants Agreement.

 

2

 

3.                                      Release of Claims — In exchange for the consideration set forth in this Agreement, which Executive acknowledges he would not otherwise be entitled to receive, Executive hereby fully, forever, irrevocably and unconditionally releases, remises and discharges the Company, its affiliates, subsidiaries, parent companies, predecessors, and successors, and all of their respective past and present officers, directors, stockholders, partners, members, employees, agents, representatives, plan administrators, attorneys, insurers and fiduciaries (each in their individual and corporate capacities) (collectively, the “Released Parties”) from any and all claims, charges, complaints, demands, actions, causes of action, suits, rights, debts, sums of money, costs, accounts, reckonings, covenants, contracts, agreements, promises, doings, omissions, damages, executions, obligations, liabilities, and expenses (including attorneys’ fees and costs), of every kind and nature that Executive ever had or now has against any or all of the Released Parties up to the date on which he signs this Agreement, whether known or unknown, including, but not limited to, any and all claims arising out of or relating to Executive’s employment with, separation or retirement from, and/or ownership of securities of the Company, including, but not limited to, all claims under Title VII of the Civil Rights Act, the Americans With Disabilities Act, the Genetic Information Nondiscrimination Act, the Family and Medical Leave Act, the Worker Adjustment and Retraining Notification Act, the Rehabilitation Act, Executive Order 11246, Executive Order 11141, the Fair Credit Reporting Act, and the Employee Retirement Income Security Act, all as amended; all claims arising out of the Massachusetts Fair Employment Practices Act, Mass. Gen. Laws ch. 151B, § 1 et seq., the Massachusetts Wage Act, Mass. Gen. Laws ch. 149, § 148 et seq. (Massachusetts law regarding payment of wages and overtime), the Massachusetts Civil Rights Act, Mass. Gen. Laws ch. 12, §§ 11H and 11I, the Massachusetts Equal Rights Act, Mass. Gen. Laws. ch. 93, § 102 and Mass. Gen. Laws ch. 214, § 1C, the Massachusetts Labor and Industries Act, Mass. Gen. Laws ch. 149, § 1 et seq., Mass. Gen. Laws ch. 214, § 1B (Massachusetts right of privacy law), the Massachusetts Maternity Leave Act, Mass. Gen. Laws ch. 149, § 105D, and the Massachusetts Small Necessities Leave Act, Mass. Gen. Laws ch. 149, § 52D, all as amended; all common law claims including, but not limited to, actions in defamation, intentional infliction of emotional distress, misrepresentation, fraud, wrongful discharge, and breach of contract (including, without limitation, all claims arising out of or related to the Employment Agreement); all state and federal whistleblower claims to the maximum extent permitted by law; and any claim or damage arising out of Executive’s employment with and/or separation from the Company (including a claim for retaliation) under any common law theory or any federal, state or local statute or ordinance not expressly referenced above; provided, however, that this release of claims shall not (i) prevent Executive from filing a charge with, cooperating with, or participating in any investigation or proceeding before, the Equal Employment Opportunity Commission or a state fair employment practices agency (except that Executive acknowledges that he may not recover any monetary benefits in connection with any such charge, investigation, or proceeding, and Executive further waives any rights or claims to any payment, benefit, attorneys’ fees or other remedial relief in connection with any such charge, investigation or proceeding), (ii) deprive Executive of his rights with respect to the Retirement Benefit, or any vested rights under any employee benefit plan or policy, stock plan or deferred compensation arrangement, or any health care continuation to the extent required by applicable law; or (iii) deprive Executive of any rights Executive may have to be indemnified by the Company as provided in any agreement between the Company and Executive or pursuant to the Company’s Certificate of Incorporation or by-laws. This release of claims shall not extend to any claims Executive may have against any persons that are Released Parties to the extent such claims are (x) related solely to Executive’s ownership of the Company’s stock and (y) unrelated to Executive’s employment relationship with the Company.

 

4.                                      Ongoing Obligations — Executive acknowledges and reaffirms his obligation, except as otherwise permitted by Section 8 below, to keep confidential and not to use or disclose any and all non-public information concerning the Company acquired by him during the course of his employment with

 

3

 

the Company, including, but not limited to, any non-public information concerning the Company’s business, operations, products, programs, affairs, performance, personnel, technology, science, intellectual property, plans, strategies, approaches, prospects, financial condition or development related matters.  Executive also acknowledges all of his continuing obligations pursuant to the Restrictive Covenants Agreement, which survive his separation from employment with the Company and shall remain in full force and effect.

 

5.                                      Non-Disparagement — Executive understands and agrees that, except as otherwise permitted by Section 8 below, he will not, in public or private, make any false, disparaging, negative, critical, adverse, derogatory or defamatory statements, whether orally or in writing, including online (including, without limitation, on any social media, networking, or employer review site) or otherwise, to any person or entity, including, but not limited to, any media outlet, industry group, key opinion leader, financial institution, research analyst or current or former employee, board member, consultant, shareholder, client or customer of the Company, regarding the Company, or any of the other Released Parties, or regarding the Company’s business, operations, products, programs, affairs, performance, personnel, technology, science, intellectual property, plans, strategies, approaches, prospects, financial condition or development related matters.  For the avoidance of doubt, the foregoing shall not prevent Executive from stating or repeating factual information with respect to the Company or its assets which is otherwise publicly available.

 

6.                                      Return of Company Property — Executive confirms that, except as he may be specifically instructed otherwise by the Board, no later than the Retirement Date (or at such earlier time as requested by the Board), he will return to the Company all property of the Company, tangible or intangible, including but not limited to keys, files, records (and copies thereof), equipment (including, but not limited to, computer hardware, software and printers, wireless handheld devices, cellular phones, tablets, etc.), Company identification and any other Company-owned property in his possession or control and that he will leave intact all electronic Company documents, including but not limited to those that he developed or helped to develop during his employment.  Executive further confirms that, except as he may be specifically instructed otherwise by the Board, no later than the Retirement Date (or at such earlier time as requested by the Company), he will cancel all accounts for his benefit, if any, in the Company’s name, including but not limited to, credit cards, telephone charge cards, cellular phone and/or wireless data accounts and computer accounts.

 

7.                                      Confidentiality — Executive understands and agrees that, except as otherwise permitted by Section 8 below, the contents of the negotiations and discussions resulting in this Agreement shall be maintained as confidential by Executive and his agents and representatives and shall not be disclosed except as otherwise agreed to in writing by the Company and except to his immediate family, legal, financial and tax advisors, on the condition that any individuals so informed must hold the above information in strict confidence.

 

8.                                      Scope of Disclosure Restrictions — Nothing in this Agreement or elsewhere prohibits Executive from communicating with government agencies about possible violations of federal, state, or local laws or otherwise providing information to government agencies, filing a complaint with government agencies, or participating in government agency investigations or proceedings.  Executive is not required to notify the Company of any such communications; provided, however, that nothing herein authorizes the disclosure of information Executive obtained through a communication that was subject to the attorney-client privilege.  Further, notwithstanding Executive’s confidentiality and nondisclosure obligations, Executive is hereby advised as follows pursuant to the Defend Trade Secrets Act: “An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to

 

4

 

an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court order.”

 

9.                                      Cooperation — Executive agrees that, to the extent permitted by law, he shall cooperate fully with the Company in the investigation, defense or prosecution of any claims or actions which already have been brought, are currently pending, or which may be brought in the future against the Company by a third party or by or on behalf of the Company against any third party, whether before a state or federal court, any state or federal government agency, or a mediator or arbitrator.  Executive’s full cooperation in connection with such claims or actions shall include, but not be limited to, being available to meet with the Company’s counsel, at reasonable times and locations designated by the Company, to investigate or prepare the Company’s claims or defenses, to prepare for trial or discovery or an administrative hearing, mediation, arbitration or other proceeding, to provide any relevant information in his possession, and to act as a witness when requested by the Company. The Company will reimburse Executive for all reasonable and documented out of pocket costs that he incurs to comply with this paragraph.  Executive further agrees that, to the extent permitted by law, he will notify the Company promptly in the event that he is served with a subpoena (other than a subpoena issued by a government agency), or in the event that he is asked to provide a third party (other than a government agency) with information concerning any actual or potential complaint or claim against the Company.

 

10.                               Amendment and Waiver — This Agreement and the Additional Release, upon their respective effective dates, shall be binding upon the Parties and may not be modified in any manner, except by an instrument in writing of concurrent or subsequent date signed by duly authorized representatives of the Parties.  This Agreement and the Additional Release are binding upon and shall inure to the benefit of the Parties and their respective agents, assigns, heirs, executors/administrators/personal representatives, and successors.  No delay or omission by the Company in exercising any right under this Agreement or the Additional Release shall operate as a waiver of that or any other right.  A waiver or consent given by the Company on any one occasion shall be effective only in that instance and shall not be construed as a bar to or waiver of any right on any other occasion.

 

11.                               Validity — Should any provision of this Agreement or the Additional Release be declared or be determined by any court of competent jurisdiction to be illegal or invalid, the validity of the remaining parts, terms or provisions shall not be affected thereby and said illegal or invalid part, term or provision shall be deemed not to be a part of this Agreement or the Additional Release.

 

12.                               Nature of Agreement — Both Parties understand and agree that this Agreement is a retirement and release of claims agreement and does not constitute an admission of liability or wrongdoing on the part of the Company or Executive.

 

13.                               Time for Consideration and Revocation — Executive acknowledges that he was initially presented with this Agreement on June 28, 2018 (the “Receipt Date”).  Executive understands that this Agreement shall be of no force or effect unless he signs and returns this Agreement on or before July 2, 2018 (the day of such execution, the “Agreement Effective Date”).  Executive further understands that he will not be eligible to receive the Retirement Benefit unless he timely signs, returns, and does not revoke the Additional Release.

 

5

 

14.                               Acknowledgments — Executive acknowledges that he has been given a reasonable amount of time to consider this Agreement, and at least twenty-one (21) days from the Receipt Date to consider the Additional Release (such 21-day period, the “Consideration Period”), and that the Company is hereby advising him to consult with an attorney of his own choosing prior to signing this Agreement and the Additional Release.  Executive further acknowledges and agrees that any changes made to this Agreement or any exhibits or attachments hereto following his initial receipt of this Agreement on the Receipt Date, whether material or immaterial, shall not re-start or affect in any manner the Consideration Period. Executive understands that he may revoke the Additional Release for a period of seven (7) days after he signs it by notifying the Company in writing, and that the release shall not be effective or enforceable until the expiration of the seven (7) day revocation period.    Executive understands and agrees that by entering into the Additional Release he will be waiving any and all rights or claims he might have under the Age Discrimination in Employment Act, as amended by the Older Workers Benefit Protection Act, and that he will have received consideration beyond that to which he was previously entitled.

 

15.                               Voluntary Assent — Executive affirms that no other promises or agreements of any kind have been made to or with Executive by any person or entity whatsoever to cause him to sign this Agreement, and that he fully understands the meaning and intent of this Agreement and that he has been represented by counsel of his own choosing.  Executive further states and represents that he has carefully read this Agreement, understands the contents herein, freely and voluntarily assents to all of the terms and conditions hereof, and signs his name of his own free act.

 

16.                               Governing Law — This Agreement and the Additional Release shall be interpreted and construed by the laws of the Commonwealth of Massachusetts, without regard to conflict of laws provisions.  Each of the Company and Executive hereby irrevocably submits to and acknowledges and recognizes the exclusive jurisdiction and venue of the courts of the Commonwealth of Massachusetts, or if appropriate, the United States District Court for the District of Massachusetts (which courts, for purposes of this Agreement and the Additional Release, are the only courts of competent jurisdiction), over any suit, action or other proceeding arising out of, under or in connection with this Agreement and the Additional Release or the subject matter thereof.

 

17.                               Entire Agreement — This Agreement, including the Additional Release and the Restrictive Covenants Agreement, contains and constitutes the entire understanding and agreement between the Parties hereto with respect to Executive’s transition, retirement and separation from the Company, and the settlement of claims against the Company, and cancels all previous oral and written negotiations, agreements, commitments and writings in connection therewith, including, without limitation, the Employment Agreement.

 

18.                               Counterparts — This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together will constitute one and the same Agreement.  Facsimile and PDF signatures shall be deemed to be of equal force and effect as originals.

 

[Remainder of page intentionally left blank]

 

6

 

IN WITNESS WHEREOF, the Parties have set their hands and seals to this Agreement as of the date(s) written below.

 

	
VOYAGER   THERAPEUTICS, INC.
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
By: 
    	
/s/ Kathleen Hayes
    	
 
    	
Date:   
    	
June 28,   2018
    
	
Name: 
    	
Kathleen Hayes
    	
 
    	
 
    	
 
    
	
Title: 
    	
Vice President, Human Resources 
    	
 
    	
 
    	
 
    

 

I hereby agree to the terms and conditions set forth above.  I have been given a reasonable amount of time to consider this Agreement and I have chosen to execute this on the date below.  I further understand that the Retirement Benefit is contingent upon my timely execution, return and non-revocation of the Additional Release, and that I have been given at least twenty-one (21) days to consider such Additional Release, and will have seven (7) days in which to revoke my acceptance after I sign such Additional Release.

 

	
Steven   M. Paul, MD
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
/s/   Steven M. Paul
    	
 
    	
Date:   
    	
June 28,   2018
    

 

[Signature Page to Retirement Agreement]

 

 

ATTACHMENT A

 

ADDITIONAL RELEASE OF CLAIMS

 

This Additional Release of Claims (this “Additional Release”) is made by Steven M. Paul, M.D. (“Executive”) as of the date set forth opposite his signature below.  Capitalized terms used but not defined herein have the meanings set forth in the Retirement Agreement to which this Additional Release is attached as Attachment A.

 

WHEREAS, Executive’s Retirement Date has occurred on or prior to the execution of this Additional Release; and

 

WHEREAS, Executive is entering into this Additional Release in accordance with the terms and conditions set forth in the Retirement Agreement.

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Executive hereby agrees as follows:

 

1.                                      Release — In consideration of the Retirement Benefit set forth in the Retirement  Agreement, which Executive acknowledges he would not otherwise be entitled to receive, Executive hereby fully, forever, irrevocably and unconditionally releases, remises and discharges the Company, its affiliates, subsidiaries, parent companies, predecessors, and successors, and all of their respective past and present officers, directors, stockholders, partners, members, employees, agents, representatives, plan administrators, attorneys, insurers and fiduciaries (each in their individual and corporate capacities) (collectively, the “Released Parties”) from any and all claims, charges, complaints, demands, actions, causes of action, suits, rights, debts, sums of money, costs, accounts, reckonings, covenants, contracts, agreements, promises, doings, omissions, damages, executions, obligations, liabilities, and expenses (including attorneys’ fees and costs), of every kind and nature that Executive ever had or now has against any or all of the Released Parties up to the date on which he signs this Additional Release, whether known or unknown, including, but not limited to, any and all claims arising out of or relating to Executive’s employment with, separation or retirement from, and/or ownership of securities of, the Company including, but not limited to, all claims under Title VII of the Civil Rights Act, the Americans With Disabilities Act, the Age Discrimination in Employment Act, the Genetic Information Nondiscrimination Act, the Family and Medical Leave Act, the Worker Adjustment and Retraining Notification Act, the Rehabilitation Act, Executive Order 11246, Executive Order 11141, the Fair Credit Reporting Act, and the Employee Retirement Income Security Act, all as amended; all claims arising out of the Massachusetts Fair Employment Practices Act, Mass. Gen. Laws ch. 151B, § 1 et seq., the Massachusetts Wage Act, Mass. Gen. Laws ch. 149, § 148 et seq. (Massachusetts law regarding payment of wages and overtime), the Massachusetts Civil Rights Act, Mass. Gen. Laws ch. 12, §§ 11H and 11I, the Massachusetts Equal Rights Act, Mass. Gen. Laws. ch. 93, § 102 and Mass. Gen. Laws ch. 214, § 1C, the Massachusetts Labor and Industries Act, Mass. Gen. Laws ch. 149, § 1 et seq., Mass. Gen. Laws ch. 214, § 1B (Massachusetts right of privacy law), the Massachusetts Maternity Leave Act, Mass. Gen. Laws ch. 149, § 105D, and the Massachusetts Small Necessities Leave Act, Mass. Gen. Laws ch. 149, § 52D, all as amended; all common law claims including, but not limited to, actions in defamation, intentional infliction of emotional distress, misrepresentation, fraud, wrongful discharge, and breach of contract; all state and federal whistleblower claims to the maximum extent permitted by law; and any claim or damage arising out of Executive’s provision of services to and/or separation from the Company (including a claim for retaliation) under any common law theory or any federal, state or local statute or ordinance not expressly referenced above; provided, however, that this release of claims shall not (i) prevent Executive from filing a charge with, cooperating with, or participating in any investigation or proceeding before, the Equal Employment Opportunity Commission or a state fair employment practices agency (except that Executive acknowledges that he may not recover any monetary

 

 

benefits in connection with any such charge, investigation, or proceeding, and Executive further waives any rights or claims to any payment, benefit, attorneys’ fees or other remedial relief in connection with any such charge, investigation or proceeding), (ii) deprive Executive of his rights with respect to the Retirement Benefit, as set forth in the Retirement Agreement, or any vested rights under any employee benefit plan or policy, stock plan or deferred compensation arrangement, or any health care continuation to the extent required by applicable law; or (iii) deprive Executive of any rights Executive may have to be indemnified by the Company as provided in any agreement between the Company and Executive or pursuant to the Company’s Certificate of Incorporation or by-laws. This release of claims shall not extend to any claims Executive may have against any persons that are Released Parties to the extent such claims are (x) related solely to Executive’s ownership of the Company’s stock and (y) unrelated to Executive’s employment relationship with the Company.

 

2.                                      Return of Company Property — Executive confirms that, except as he has been specifically instructed otherwise by the Board, he has returned to the Company all property of the Company, tangible or intangible, including but not limited to keys, files, records (and copies thereof), equipment (including, but not limited to, computer hardware, software and printers, wireless handheld devices, cellular phones, tablets, etc.), Company identification and any other Company-owned property in his possession or control and that he has left intact all electronic Company documents, including but not limited to those that he developed or helped to develop during his employment. Executive further confirms that, except as he has been specifically instructed otherwise by the Board, he has canceled all accounts for his benefit, if any, in the Company’s name, including but not limited to, credit cards, telephone charge cards, cellular phone and/or wireless data accounts and computer accounts.

 

3.                                      Business Expenses; Final Compensation — Executive acknowledges that he has been reimbursed by the Company for all business expenses incurred in conjunction with the performance of his employment and that no other reimbursements are owed to him.  Executive further acknowledges that he has received all compensation due to him from the Company, including, but not limited to, all wages, bonuses and accrued, unused vacation time, and that he is not eligible or entitled to receive any additional payments or consideration from the Company beyond the Retirement Benefit.

 

4.                                      Time for Consideration; Acknowledgments — Executive acknowledges that, in order to receive the Retirement Benefit, he must sign and return this Additional Release on, but not before the Retirement Date (provided, however, that if the Retirement Date is fewer than twenty-one (21) days following the Receipt Date, he must sign and return this Additional Release no earlier than the Retirement Date and no later than the twenty-second (22nd) day after the Receipt Date) and he must continue to comply with his obligations under the Restrictive Covenants Agreement (as defined in the Retirement Agreement).  Executive acknowledges that he has been given at least twenty-one (21) days to consider this Additional Release, and that the Company advised him to consult with an attorney of his own choosing prior to signing this Additional Release.  Executive understands that he may revoke this Additional Release for a period of seven (7) days after he signs it by notifying the Company in writing, and the Additional Release shall not be effective or enforceable until the expiration of this seven (7) day revocation period (the day immediately following expiration of such revocation period.  In the event Executive executes this Additional Release within fewer than twenty-one (21) days after the Receipt Date, he acknowledges that such decision is entirely voluntary and that he has had the opportunity to consider such release until the end of the twenty-one (21) day period.  Executive understands and agrees that by entering into this Additional Release, he is waiving any and all rights or claims he might have under the Age Discrimination in Employment Act, as amended by the Older Workers Benefit Protection Act, and that he has received consideration beyond that to which he was previously entitled.

 

5.                                      Voluntary Assent — Executive affirms that no other promises or agreements of any kind have been made to or with him by any person or entity whatsoever to cause him to sign this Additional Release, and

 

 

that he fully understands the meaning and intent of this Additional Release.  Executive states and represents that he has had an opportunity to fully discuss and review the terms of this Additional Release with an attorney. Executive further states and represents that he has carefully read this Additional Release, understands the contents herein, freely and voluntarily assents to all of the terms and conditions hereof, and signs his name of his own free act.

 

For the avoidance of doubt, this Additional Release supplements, and in no way limits, the Retirement Agreement.

 

I hereby provide this Additional Release as of the current date and acknowledge that the execution of this Additional Release is in further consideration of the Retirement Benefit, to which I acknowledge I would not be entitled if I did not enter into this Additional Release.  I intend that this Additional Release will become a binding agreement between me and the Company if I do not revoke my acceptance in seven (7) days.

 

	
Steven   M. Paul, M.D.
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00285-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00285-of-00352.parquet"}]]